Disease by developmental or physiological process
MONDO:7770007A grouping class for human diseases classified by the molecular, biochemical, cellular, anatomic, developmental or physiological process that is disrupted.
36161 clinical trials for this condition and its sub-types, 0 tagged with Disease by developmental or physiological process itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Disease by developmental or physiological process
-
Psychiatric disorder 483 trials · 12,298 incl. sub-types
14 sub-types
- Mental disorder 249 trials · 7,372 incl. sub-types Sub-types →
- Cognitive disorder 443 trials · 3,167 incl. sub-types Sub-types →
- Substance-related disorder 557 trials · 2,315 incl. sub-types Sub-types →
- Eating disorder 157 trials · 362 incl. sub-types Sub-types →
- Personality disorder 24 trials · 171 incl. sub-types Sub-types →
- Somatoform disorder 47 trials · 127 incl. sub-types Sub-types →
- Impulse control disorder 21 trials · 66 incl. sub-types Sub-types →
- Sexual disorder 3 trials · 66 incl. sub-types Sub-types →
- Enuresis 9 trials · 32 incl. sub-types Sub-types →
- Dissociative disorder 16 trials · 19 incl. sub-types Sub-types →
- Catatonia 12 trials Sub-types →
- Alice in Wonderland syndrome 0 trials
- Body integrity dysphoria 0 trials
- Factitious disorder 0 trials Sub-types →
-
Inflammatory disease 348 trials · 10,833 incl. sub-types
94 sub-types
- Arthritic joint disease 194 trials · 2,548 incl. sub-types Sub-types →
- Dermatitis 65 trials · 1,623 incl. sub-types Sub-types →
- Gastroenteritis 20 trials · 837 incl. sub-types Sub-types →
- Hepatitis 50 trials · 731 incl. sub-types Sub-types →
- Pneumonitis 15 trials · 645 incl. sub-types Sub-types →
- Periodontitis 436 trials · 600 incl. sub-types Sub-types →
- Mucositis 22 trials · 552 incl. sub-types Sub-types →
- Nephritis 16 trials · 503 incl. sub-types Sub-types →
- Myositis disease 105 trials · 298 incl. sub-types Sub-types →
- Keratitis 6 trials · 296 incl. sub-types Sub-types →
- Conjunctivitis 6 trials · 286 incl. sub-types Sub-types →
- Vasculitis 63 trials · 286 incl. sub-types Sub-types →
- Encephalomyelitis 3 trials · 226 incl. sub-types Sub-types →
- Pancreatitis 120 trials · 203 incl. sub-types Sub-types →
- Pulpitis 191 trials
- Cholangitis 17 trials · 139 incl. sub-types Sub-types →
- Hidradenitis 21 trials · 135 incl. sub-types Sub-types →
- Sinusitis 44 trials · 130 incl. sub-types Sub-types →
- Bursitis 111 trials · 119 incl. sub-types Sub-types →
- Spondylitis 8 trials · 119 incl. sub-types Sub-types →
- Inflammation of heart layer 1 trial · 114 incl. sub-types Sub-types →
- Esophagitis 22 trials · 102 incl. sub-types Sub-types →
- Vaginitis 11 trials · 102 incl. sub-types Sub-types →
- Fasciitis 7 trials · 97 incl. sub-types Sub-types →
- Epicondylitis 86 trials
- Cystitis 12 trials · 72 incl. sub-types Sub-types →
- Uveitis 37 trials · 67 incl. sub-types Sub-types →
- Chronic inflammatory demyelinating polyradiculoneuropathy 62 trials Sub-types →
- Thyroiditis 1 trial · 62 incl. sub-types Sub-types →
- Otitis media 39 trials · 60 incl. sub-types Sub-types →
- Serositis 0 trials · 58 incl. sub-types Sub-types →
- Tracheobronchitis 5 trials · 55 incl. sub-types Sub-types →
- Gastritis 21 trials · 50 incl. sub-types Sub-types →
- Pharyngitis 34 trials · 43 incl. sub-types Sub-types →
- Ear infection 9 trials · 40 incl. sub-types Sub-types →
- Endophthalmitis 9 trials · 38 incl. sub-types Sub-types →
- Chronic granulomatous disease 37 trials Sub-types →
- Nasopharyngitis 6 trials · 37 incl. sub-types Sub-types →
- Diverticulitis 28 trials · 34 incl. sub-types Sub-types →
- Neuritis 18 trials · 29 incl. sub-types Sub-types →
- Blepharitis 11 trials · 28 incl. sub-types Sub-types →
- Tonsillitis 23 trials · 27 incl. sub-types Sub-types →
- Vulvitis 0 trials · 27 incl. sub-types Sub-types →
- Pericarditis 20 trials · 24 incl. sub-types Sub-types →
- Lymphadenitis 3 trials · 22 incl. sub-types Sub-types →
- Myelin oligodendrocyte glycoprotein antibody-associated disease 22 trials Sub-types →
- Proctitis 2 trials · 21 incl. sub-types Sub-types →
- Neuronitis 20 trials
- Rheumatic heart disease 17 trials Sub-types →
- Periostitis 0 trials · 16 incl. sub-types Sub-types →
- Prostatitis 4 trials · 15 incl. sub-types Sub-types →
- Pelvic inflammatory disease 4 trials · 14 incl. sub-types Sub-types →
- Immune reconstitution inflammatory syndrome 11 trials
- Mastitis 11 trials Sub-types →
- Chorioamnionitis 10 trials
- Perianal Crohn disease 10 trials
- Labyrinthitis 0 trials · 9 incl. sub-types Sub-types →
- Laryngitis 2 trials · 8 incl. sub-types Sub-types →
- Mediastinitis 6 trials
- Panniculitis 3 trials · 6 incl. sub-types Sub-types →
- Urethritis 5 trials · 6 incl. sub-types Sub-types →
- Thromboangiitis obliterans 4 trials
- STING-associated vasculopathy with onset in infancy 2 trials
- Chronic inflammation of lacrimal passage 0 trials · 2 incl. sub-types Sub-types →
- Dacryocystitis 1 trial · 2 incl. sub-types Sub-types →
- Enthesitis 2 trials
- Epididymitis 2 trials Sub-types →
- Omphalitis 2 trials Sub-types →
- Orchitis 1 trial · 2 incl. sub-types Sub-types →
- Balanitis 0 trials · 1 incl. sub-types Sub-types →
- Glossitis 0 trials · 1 incl. sub-types Sub-types →
- Isolated anogenital granulomatosis 1 trial
- Mastoiditis 1 trial
- Oophoritis 0 trials · 1 incl. sub-types Sub-types →
- Radiculitis 1 trial
- IgG4-related pachymeningitis 0 trials
- Amnionitis 0 trials
- Cheilitis 0 trials Sub-types →
- Chronic pneumonitis of infancy 0 trials
- Dacryoadenitis 0 trials Sub-types →
- Diaphragmitis 0 trials
- Endocervicitis 0 trials
- Geniculate ganglionitis 0 trials
- Gonococcal cervicitis 0 trials Sub-types →
- Multiple evanescent white dot syndrome 0 trials
- Oral tuberculosis 0 trials
- Parotitis 0 trials
- Perinephritis 0 trials
- Petrositis 0 trials
- Placental villitis 0 trials
- Posthitis 0 trials Sub-types →
- Pyometritis 0 trials Sub-types →
- Ureteritis 0 trials
- Uvulitis 0 trials
-
Metabolic disease 245 trials · 7,349 incl. sub-types
37 sub-types
- Glucose metabolism disease 62 trials · 4,125 incl. sub-types Sub-types →
- Inborn errors of metabolism 48 trials · 2,228 incl. sub-types Sub-types →
- Proteostasis deficiencies 1 trial · 559 incl. sub-types Sub-types →
- Hyperlipidemia 306 trials · 400 incl. sub-types Sub-types →
- Carbohydrate metabolism disease 4 trials · 384 incl. sub-types Sub-types →
- Developmental anomaly of metabolic origin 0 trials · 383 incl. sub-types Sub-types →
- Diabetic retinopathy 148 trials · 260 incl. sub-types Sub-types →
- Acquired metabolic disease 0 trials · 182 incl. sub-types Sub-types →
- Amino acid metabolism disease 2 trials · 160 incl. sub-types Sub-types →
- Disorder of organic acid metabolism 0 trials · 154 incl. sub-types Sub-types →
- Mineral metabolism disease 2 trials · 137 incl. sub-types Sub-types →
- Diabetic kidney disease 133 trials
- Hyperlipoproteinemia 8 trials · 106 incl. sub-types Sub-types →
- Steroid metabolism disease 1 trial · 104 incl. sub-types Sub-types →
- Gout 102 trials
- Disorder of GPI anchor biosynthesis 0 trials · 73 incl. sub-types Sub-types →
- Hypertriglyceridemia 73 trials Sub-types →
- Porphyrin metabolism disease 0 trials · 64 incl. sub-types Sub-types →
- Bilirubin metabolism disease 0 trials · 48 incl. sub-types Sub-types →
- Lipodystrophy 30 trials · 48 incl. sub-types Sub-types →
- Disorder of acid-base balance 6 trials · 28 incl. sub-types Sub-types →
- Vitamin B12 deficiency 12 trials · 15 incl. sub-types Sub-types →
- Purine metabolism disease 0 trials · 14 incl. sub-types Sub-types →
- Pyrimidine metabolism disease 0 trials · 11 incl. sub-types Sub-types →
- Lactic acidosis 8 trials Sub-types →
- Chondrocalcinosis 5 trials · 7 incl. sub-types Sub-types →
- Hypoalphalipoproteinemia 1 trial · 7 incl. sub-types Sub-types →
- Glutaric aciduria 0 trials · 5 incl. sub-types Sub-types →
- Tumor lysis syndrome 3 trials
- Dopa-responsive dystonia 1 trial · 2 incl. sub-types Sub-types →
- Ochronosis disorder 1 trial Sub-types →
- Xanthinuria 0 trials · 1 incl. sub-types Sub-types →
- Xanthoma 1 trial Sub-types →
- Collagenous sprue 0 trials
- Disorder of glutamate decarboxylase 0 trials
- Skeletal fluorosis 0 trials
- Steroid dehydrogenase deficiency-dental anomalies syndrome 0 trials
-
Disorder of development or morphogenesis 0 trials · 5,170 incl. sub-types
190 sub-types
- Neurocristopathy 0 trials · 1,553 incl. sub-types Sub-types →
- Developmental defect during embryogenesis 8 trials · 1,057 incl. sub-types Sub-types →
- Demyelinating disease 27 trials · 931 incl. sub-types Sub-types →
- Congenital anomaly of cardiovascular system 5 trials · 595 incl. sub-types Sub-types →
- Bone development disease 2 trials · 527 incl. sub-types Sub-types →
- Aortic valve stenosis 319 trials · 322 incl. sub-types Sub-types →
- Bronchopulmonary dysplasia 96 trials
- Spina bifida 44 trials · 59 incl. sub-types Sub-types →
- Overgrowth syndrome 1 trial · 49 incl. sub-types Sub-types →
- Hypospadias 35 trials Sub-types →
- Cleft lip/palate 31 trials Sub-types →
- Keratinization disease 1 trial · 31 incl. sub-types Sub-types →
- Noonan syndrome and Noonan-related syndrome 1 trial · 28 incl. sub-types Sub-types →
- Lactation disease 18 trials · 24 incl. sub-types Sub-types →
- Anterior segment dysgenesis 2 trials · 21 incl. sub-types Sub-types →
- Familial bicuspid aortic valve 6 trials · 21 incl. sub-types Sub-types →
- Precocious puberty 18 trials · 19 incl. sub-types Sub-types →
- Cleft lip and alveolus 17 trials Sub-types →
- Isolated short stature 16 trials
- Aorta coarctation 13 trials Sub-types →
- Microcephaly 4 trials · 13 incl. sub-types Sub-types →
- Anorectal malformation 10 trials Sub-types →
- Multicystic dysplastic kidney 1 trial · 10 incl. sub-types Sub-types →
- Polydactyly 2 trials · 9 incl. sub-types Sub-types →
- Syndactyly 3 trials · 9 incl. sub-types Sub-types →
- Aniridia 8 trials Sub-types →
- Cerebral cortical dysplasia 2 trials · 7 incl. sub-types Sub-types →
- Familial isolated congenital asplenia 6 trials
- Imperforate anus 6 trials
- Septate uterus 6 trials Sub-types →
- Congenital primary megaureter 5 trials Sub-types →
- Congenital portosystemic shunt 4 trials Sub-types →
- Diabetic embryopathy 4 trials Sub-types →
- Familial partial lipodystrophy, Dunnigan type 4 trials
- Camptodactyly of fingers 3 trials
- Congenital hydrocephalus 1 trial · 3 incl. sub-types Sub-types →
- Congenital pulmonary airway malformation 3 trials Sub-types →
- Megalencephaly 3 trials Sub-types →
- Aicardi syndrome 2 trials
- Joubert syndrome 2 trials Sub-types →
- Congenital deformities of limbs 2 trials Sub-types →
- Congenital knee dislocation 0 trials · 2 incl. sub-types Sub-types →
- Congenital tricuspid malformation 0 trials · 2 incl. sub-types Sub-types →
- Constitutional delay of growth and puberty 2 trials
- Duodenal atresia 2 trials
- Hereditary gingival fibromatosis 0 trials · 2 incl. sub-types Sub-types →
- Renal agenesis 1 trial · 2 incl. sub-types Sub-types →
- 46,XY complete gonadal dysgenesis 0 trials · 1 incl. sub-types Sub-types →
- Berardinelli-Seip congenital lipodystrophy 0 trials · 1 incl. sub-types Sub-types →
- COACH syndrome 1 trial Sub-types →
- DNA ligase IV deficiency 1 trial
- L1 syndrome 0 trials · 1 incl. sub-types Sub-types →
- Rothmund-Thomson syndrome 1 trial Sub-types →
- T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency 1 trial
- Agenesis and aplasia of uterine body 1 trial
- Amelogenesis imperfecta type 1G 1 trial
- Bronchogenic cyst 1 trial
- Cephalocele 0 trials · 1 incl. sub-types Sub-types →
- Colonic atresia 1 trial
- Congenital bilateral absence of vas deferens 1 trial Sub-types →
- Hereditary lethal multiple congenital anomalies/dysmorphic syndrome 0 trials · 1 incl. sub-types Sub-types →
- Horizontal gaze palsy with progressive scoliosis 1 trial Sub-types →
- Hypohidrotic ectodermal dysplasia 1 trial Sub-types →
- Isolated cerebellar hypoplasia/agenesis 1 trial
- Isolated congenital femoral bifurcation 1 trial
- Isolated micropenis 1 trial
- Low anorectal malformation 1 trial
- Macrocephaly-autism syndrome 1 trial
- Medullary sponge kidney 1 trial
- Megalodactyly 1 trial
- Multiple intestinal atresia 0 trials · 1 incl. sub-types Sub-types →
- Pancreatic agenesis 0 trials · 1 incl. sub-types Sub-types →
- Primary basilar invagination 1 trial
- Renal hypoplasia 1 trial Sub-types →
- Bloom syndrome 0 trials
- CK syndrome 0 trials
- Chudley-McCullough syndrome 0 trials
- Eng-Strom syndrome 0 trials
- Fowler syndrome 0 trials
- Jalili syndrome 0 trials
- Lowe-Kohn-Cohen syndrome 0 trials
- Morgagni-Stewart-Morel syndrome 0 trials
- Nance-Horan syndrome 0 trials
- Ogden syndrome 0 trials
- X-linked intellectual disability-corpus callosum agenesis-spastic quadriparesis syndrome 0 trials
- Acalvaria 0 trials
- Aneurysm of sinus of Valsalva 0 trials
- Aprosencephaly 0 trials
- Atelencephaly 0 trials
- Atresia of small intestine 0 trials
- Atypical Werner syndrome 0 trials
- Autosomal recessive frontotemporal pachygyria 0 trials
- Axial mesodermal dysplasia spectrum 0 trials
- Bicornuate uterus 0 trials Sub-types →
- Biliary atresia with splenic malformation syndrome 0 trials
- Blepharoptosis-cleft palate-ectrodactyly-dental anomalies syndrome 0 trials
- Brachydactyly 0 trials Sub-types →
- Branchial arch disease 0 trials
- Cardiac valvular defect, developmental 0 trials
- Cartilage development disorder 0 trials
- Cataract - congenital heart disease - neural tube defect syndrome 0 trials
- Cleft palate-stapes fixation-oligodontia syndrome 0 trials
- Complex cortical dysplasia with other brain malformations 0 trials Sub-types →
- Congenital absence of septum pellucidum 0 trials
- Congenital achiasma 0 trials
- Congenital agenesis of the scrotum 0 trials
- Congenital anomaly of hepatic vein 0 trials
- Congenital anomaly of superior vena cava 0 trials Sub-types →
- Congenital aortic valve insufficiency 0 trials
- Congenital bronchobiliary fistula 0 trials
- Congenital elbow dislocation 0 trials Sub-types →
- Congenital esophageal diverticulum 0 trials
- Congenital generalized hypercontractile muscle stiffness syndrome 0 trials
- Congenital high airway obstruction syndrome 0 trials
- Congenital microgastria 0 trials
- Congenital patella dislocation 0 trials Sub-types →
- Congenital peritoneal encapsulation 0 trials
- Congenital short bowel syndrome 0 trials Sub-types →
- Congenital shoulder dislocation 0 trials
- Cordiform uterus 0 trials
- Coronary sinus atresia 0 trials
- Coronary sinus stenosis 0 trials
- Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome 0 trials
- Craniodiaphyseal dysplasia 0 trials
- Craniofacial dysplasia - osteopenia syndrome 0 trials
- Craniofacial dyssynostosis 0 trials
- Craniorachischisis 0 trials
- Deafness-oligodontia syndrome 0 trials
- Dentinogenesis imperfecta-short stature-hearing loss-intellectual disability syndrome 0 trials
- Diencephalic-mesencephalic junction dysplasia 0 trials Sub-types →
- Diphallia 0 trials
- Diprosopus 0 trials
- Distal symphalangism 0 trials
- Double uterus-hemivagina-renal agenesis syndrome 0 trials
- Duplication of the pituitary gland 0 trials
- Duplication of urethra 0 trials
- Epibulbar lipodermoid-preauricular appendage-polythelia syndrome 0 trials
- Familial intestinal malrotation-facial anomalies syndrome 0 trials
- Familial isolated clinodactyly of fingers 0 trials
- Familial median cleft of the upper and lower lips 0 trials
- Familial omphalocele syndrome with facial dysmorphism 0 trials
- Familial osteodysplasia, Anderson type 0 trials
- Familial primary pulmonary hypoplasia 0 trials
- Gingival fibromatosis-progressive deafness syndrome 0 trials
- High anorectal malformation 0 trials
- Hypogonadotropic hypogonadism-severe microcephaly-sensorineural hearing loss-dysmorphism syndrome 0 trials
- Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome 0 trials
- Intermediate anorectal malformation 0 trials
- Isolated cleft lip 0 trials Sub-types →
- Isolated congenital digital clubbing 0 trials
- Isolated congenital syngnathia 0 trials
- Isolated partial vaginal agenesis 0 trials
- Isolated splenogonadal fusion 0 trials
- Lissencephaly spectrum disorders 0 trials Sub-types →
- Longitudinal vaginal septum 0 trials
- Loose anagen syndrome 0 trials Sub-types →
- Lower limb hypertrophy 0 trials
- Lung agenesis-heart defect-thumb anomalies syndrome 0 trials
- Macrodactyly of fingers 0 trials Sub-types →
- Macrodactyly of toes 0 trials Sub-types →
- Maternal hyperthermia induced birth defects 0 trials
- Microcephaly-polymicrogyria-corpus callosum agenesis syndrome 0 trials
- Mulibrey nanism 0 trials
- Natal teeth-intestinal pseudoobstruction-patent ductus syndrome 0 trials
- Non-eruption of teeth-maxillary hypoplasia-genu valgum syndrome 0 trials
- Oculocerebral hypopigmentation syndrome, Cross type 0 trials
- Oculodental syndrome, Rutherfurd type 0 trials
- Odontomatosis-aortae esophagus stenosis syndrome 0 trials
- Otodental syndrome 0 trials
- Penoscrotal transposition 0 trials
- Pericardial and diaphragmatic defect 0 trials
- Porencephaly-microcephaly-bilateral congenital cataract syndrome 0 trials
- Postaxial polydactyly-dental and vertebral anomalies syndrome 0 trials
- Posterior hypospadias 0 trials
- Progeroid features-hepatocellular carcinoma predisposition syndrome 0 trials
- Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome 0 trials
- Pulmonary agenesis 0 trials
- Renal dysplasia 0 trials Sub-types →
- Renal tubular dysgenesis of genetic origin 0 trials Sub-types →
- Steatocystoma multiplex-natal teeth syndrome 0 trials
- Steroid dehydrogenase deficiency-dental anomalies syndrome 0 trials
- Subaortic stenosis, membranous 0 trials
- Thumb deformity-alopecia-pigmentation anomaly syndrome 0 trials
- Torticollis-keloids-cryptorchidism-renal dysplasia syndrome 0 trials
- Tracheal agenesis 0 trials
- Transverse vaginal septum 0 trials
- Upper limb hypertrophy 0 trials
- Uterine cervical aplasia and agenesis 0 trials
- Uterine hypoplasia 0 trials
- Vaginal atresia 0 trials
-
Sleep disorder 507 trials · 2,089 incl. sub-types
5 sub-types
- Sleep-wake disorder 179 trials · 1,049 incl. sub-types Sub-types →
- Insomnia 822 trials · 826 incl. sub-types Sub-types →
- Parasomnia, sleepwalking type 4 trials
- Parasomnia, sleep terrors type 2 trials
- Nocturnal paroxysmal dystonia 0 trials
-
Disease by molecular mechanism 2 trials · 1,826 incl. sub-types
5 sub-types
- Tauopathy 24 trials · 1,190 incl. sub-types Sub-types →
- Proteostasis deficiencies 1 trial · 559 incl. sub-types Sub-types →
- RASopathy 9 trials · 100 incl. sub-types Sub-types →
- Ciliopathy 2 trials · 49 incl. sub-types Sub-types →
- Muscular channelopathy 0 trials · 19 incl. sub-types Sub-types →
-
Obstetric disorder 22 trials · 1,019 incl. sub-types
2 sub-types
- Pregnancy disorder 307 trials · 941 incl. sub-types Sub-types →
- Puerperal disorder 79 trials · 89 incl. sub-types Sub-types →
-
Ulcer disease 58 trials · 141 incl. sub-types
3 sub-types
- Peptic ulcer disease 26 trials · 67 incl. sub-types Sub-types →
- Esophageal ulcer 1 trial · 25 incl. sub-types Sub-types →
- Corneal ulcer 16 trials · 18 incl. sub-types Sub-types →
-
Mitochondrial disease 40 trials · 132 incl. sub-types
12 sub-types
- Inborn mitochondrial metabolism disorder 59 trials · 127 incl. sub-types Sub-types →
- ACO2-related optic atrophy with or without extraocular features 0 trials Sub-types →
- Bjornstad syndrome 0 trials
- FDXR-related optic atrophy mitochondrial dysfunction syndrome 0 trials Sub-types →
- GRACILE syndrome 0 trials
- X-linked sideroblastic anemia with ataxia 0 trials
- Autosomal dominant optic atrophy plus syndrome 0 trials Sub-types →
- Ethylmalonic encephalopathy 0 trials
- Hereditary myopathy with lactic acidosis due to ISCU deficiency 0 trials
- Maternally-inherited cardiomyopathy and hearing loss 0 trials
- Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency 0 trials
- Pure mitochondrial myopathy 0 trials
-
Premature aging syndrome 6 trials · 109 incl. sub-types
8 sub-types
- Telomere syndrome 9 trials · 92 incl. sub-types Sub-types →
- Progeroid syndrome 3 trials · 11 incl. sub-types Sub-types →
- Flynn-Aird syndrome 0 trials
- LMNA-related cardiocutaneous progeria syndrome 0 trials
- Acrogeria 0 trials
- Acroosteolysis-keloid-like lesions-premature aging syndrome 0 trials
- De Barsy syndrome 0 trials Sub-types →
- Premature aging syndrome, Okamoto type 0 trials
-
Disorder of glycosylation 0 trials · 74 incl. sub-types
4 sub-types
- Disorder of GPI anchor biosynthesis 0 trials · 73 incl. sub-types Sub-types →
- DHDDS-CDG 1 trial Sub-types →
- Congenital myasthenic syndrome 12 0 trials
- Schneckenbecken dysplasia 0 trials
-
Perinatal disease 42 trials
1 sub-type
Most studied deeper sub-types
Showing the 400 most recently updated of 941 trials in this tab.
-
Can a One-Time gene therapy fix fabry disease for years?
Cure Stopped earlyThis study follows people with Fabry disease who have already received FLT190, an experimental gene therapy that delivers a working copy of the GLA gene. The goal is to see how safe the treatment is over the long term and whether its effects last. Researchers will track participa…
Phase 1/2 • Sponsor: Spur Therapeutics • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
Can a single gene infusion rewrite the story of fabry disease?
Cure Stopped earlyThis trial is testing a gene therapy called FLT190 in adult men with classic Fabry disease, a genetic condition that causes harmful fat buildup in cells. The therapy uses a modified virus to deliver a working copy of the faulty gene, potentially enabling the body to produce the m…
Phase 1/2 • Sponsor: Spur Therapeutics • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
New pill takes aim at stubborn blood sugar
Disease control Stopped earlyResearchers are testing an experimental oral drug called MBX-102 in adults with type 2 diabetes whose blood sugar remains too high on metformin alone. The trial compares two doses of MBX-102 with a placebo and with Actos, an approved diabetes drug. About 242 participants take the…
Phase 2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for lung scarring? trial of GSK3915393 cut short
Disease control Stopped earlyThis study tested a new medicine, GSK3915393, in 158 people with idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes scarring and breathing difficulty. The goal was to see if the drug could slow lung function decline compared to a placebo. The trial was termin…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Experimental drug targets dangerous calcium spike in cancer
Disease control Stopped earlyResearchers are testing an experimental drug called JMT103 in adults with cancer whose blood calcium levels are dangerously high and who have not responded to standard intravenous bisphosphonate treatment. Participants receive JMT103 as an injection under the skin every four week…
Phase 1/2 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug bulevirtide tracked in real-world hepatitis d patients
Disease control Stopped earlyThis study follows 170 people with chronic hepatitis D who are taking bulevirtide to see how well it works over time and what side effects may occur. Researchers will track serious liver problems like liver failure, cancer, or need for transplant. The goal is to understand the dr…
Sponsor: Gilead Sciences • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy shows promise for kids with tough cancers
Disease control Stopped earlyThis study tested a combination of an immunotherapy drug (nivolumab) and low-dose chemotherapy in children and teenagers whose solid tumors had not responded to standard treatments. The goal was to see if the combination was safe and could help control the cancer. The trial was s…
Phase 1/2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug aims to slow Alzheimer's in early stages
Disease control Stopped earlyThis study tests an experimental drug called GSK4527226 in 367 people with early Alzheimer's (mild memory problems or mild dementia). Participants receive either a low dose, high dose, or placebo through an IV. The goal is to see if the drug can slow down declines in memory and d…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Double-Drug attack on Hard-to-Treat lymphomas
Disease control Stopped earlyResearchers are testing whether combining two chemotherapy drugs, pralatrexate and romidepsin, is safe and effective for people with lymphoid cancers that have returned or stopped responding to treatment. The trial first finds the highest dose people can tolerate, then gives that…
Phase 1/2 • Sponsor: Jennifer Amengual • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New combo tackles tough melanoma
Disease control Stopped earlyThis phase II trial is testing whether a combination of two drugs, rigosertib and pembrolizumab, can help people with advanced melanoma that no longer responds to standard immunotherapy. The study involves 7 participants with unresectable or metastatic melanoma. The goal is to se…
Phase 2 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Ear drops after tube surgery: do they prevent blockage?
Disease control Stopped earlyThis study looked at whether using antibiotic ear drops during and after ear tube surgery reduces the chance of tube blockage or ear drainage in children. Only 9 children took part, and each child received drops in one ear but not the other. The study was stopped early, so the fi…
Phase 4 • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Could a blood pressure drug combo tame panic attacks?
Disease control Stopped earlyThis phase 2 trial tests a new drug called HB-1, which combines two blood pressure medicines (telmisartan and verapamil), to see if it can reduce unexpected panic attacks in people with panic disorder. The study plans to enroll 240 adults aged 18 to 65 and compare HB-1 against pl…
Phase 2 • Sponsor: HB BioTech, LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
Disease control Stopped earlyResearchers are testing an experimental drug called LY2140023 in people with schizophrenia who have already completed a short-term trial of the same drug. The study compares LY2140023 to standard antipsychotic medications like olanzapine, aripiprazole, risperidone, and quetiapine…
Phase 2/3 • Sponsor: Denovo Biopharma LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New inhaled therapy aims to save ventilator patients from viral pneumonia
Disease control Stopped earlyThis study tests an inhaled medicine called SNG001 in patients with severe viral pneumonia who need a breathing machine. The goal is to see if it safely helps clear the virus faster and lowers the risk of death. About 550 adults, mostly over 50 or with weakened immune systems, wi…
Phase 2 • Sponsor: Synairgen Research Ltd. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Five-Year safety check for experimental schizophrenia drug
Disease control Stopped earlyResearchers are studying the long-term safety of pomaglumetad methionil, an experimental drug taken by mouth, in adults with schizophrenia. About 129 participants receive the drug and are monitored for up to five years. The study tracks movement side effects, weight, blood sugar,…
Phase 3 • Sponsor: Denovo Biopharma LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New depression drug tested for long-term safety in 1,000 patients
Disease control Stopped earlyThis study looks at the long-term safety and effectiveness of an experimental drug called NMRA-335140 for people with major depressive disorder. About 1,000 adults who completed earlier studies of this drug will take it for 52 weeks. Researchers will track side effects and change…
Phase 3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Slower magnesium drip may help sickest patients hold onto the mineral
Disease control Stopped earlyCritically ill patients often have low magnesium, which can lead to heart rhythm problems and other complications. When magnesium is given through an IV, the body keeps only about half of it. Researchers are testing whether giving the same dose over 8 hours instead of 4 hours hel…
Sponsor: CAMC Health System • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can an immune booster make chemo hit melanoma harder?
Disease control Stopped earlyResearchers are testing an experimental immunotherapy called ALT-801 alongside the chemotherapy drug cisplatin in people with metastatic melanoma that cannot be cured with surgery. The trial enrolls about 22 participants who have not received prior chemotherapy for their melanoma…
Phase 1/2 • Sponsor: Altor BioScience • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New hope for High-Risk melanoma: combo therapy aims to prevent recurrence
Disease control Stopped earlyThis study tested whether adding vibostolimab to the standard immunotherapy pembrolizumab can better prevent melanoma from returning after surgery. About 1,600 people with high-risk stage II to IV melanoma took part. The goal was to see if the combination keeps cancer away longer…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Spinal injection drug targets genetic cause of ALS and dementia
Disease control Stopped earlyResearchers are testing repeated doses of an experimental drug called WVE-004 in adults who have ALS, frontotemporal dementia, or both, linked to a mutation in the C9orf72 gene. Participants receive the drug by spinal injection every 12 weeks for up to 96 weeks. The study tracks …
Phase 1/2 • Sponsor: Wave Life Sciences USA, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Experimental drug auxora tested in critical COVID-19 lung patients
Disease control Stopped earlyThis small Phase 2 trial tested an experimental drug called Auxora in 10 patients with critical COVID-19 pneumonia who were on ventilators. The goal was to see how the drug affected immune cells in the lungs and to check its safety. The study was terminated early, so results are …
Phase 2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a plastic meniscus implant keep knees Pain-Free for years?
Disease control Stopped earlyThis registry study follows people who receive the NUsurface meniscus implant, a device designed to replace a damaged meniscus in the knee. Researchers track pain and knee function over time using standard scores like KOOS and WOMET. The goal is to see how well the implant works …
Sponsor: Phoenix Kinetics • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can an oral drug calm inflamed muscles in myositis?
Disease control Stopped earlyResearchers are testing an experimental oral drug called enpatoran in adults with dermatomyositis and polymyositis, two rare muscle-weakening diseases. Participants receive enpatoran or a placebo twice daily for up to 24 weeks while continuing their standard care. The trial measu…
Phase 2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a Melatonin-Like pill slow Alzheimer's memory loss?
Disease control Stopped earlyResearchers are testing whether piromelatine 20 mg, a tablet that acts on melatonin and serotonin receptors, can slow cognitive decline in people aged 60 to 85 with mild dementia from Alzheimer's disease. The study enrolls 216 participants who do not carry a specific genetic vari…
Phase 2/3 • Sponsor: Neurim Pharmaceuticals Ltd. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can AI and peer support close the opioid treatment gap?
Disease control Stopped earlyThis trial tests whether an AI-driven texting tool, combined with support from peer recovery coaches, can help Black and Latinx people who use opioids start buprenorphine treatment in primary care. Participants are enrolled from emergency departments and receive text messages wit…
Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New combo therapy shows promise in early sarcoma trial
Disease control Stopped earlyThis study tests a new drug (ADI-PEG 20) combined with chemotherapy and radiation before surgery for soft tissue sarcoma. The goal is to find the safest dose and see how well it shrinks tumors. Only 6 patients with intermediate or high-grade sarcoma of the trunk or limbs are taki…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Kava drink tested to help smokers cut down and lower cancer risk
Disease control Stopped earlyThis study tests whether a daily kava drink can help active smokers who don't plan to quit reduce their smoking and lower their risk of lung cancer. Twenty adult smokers will take kava daily for several months. Researchers will check how well participants stick with the regimen, …
Phase 2 • Sponsor: University of Florida • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could CAR-T cells tame tough lupus kidney disease?
Disease control Stopped earlyThis early-phase trial is testing a new treatment called KYV-101, which uses a patient's own modified immune cells (CAR-T cells) to target and destroy faulty B cells that drive lupus kidney inflammation. The study involves 6 adults with lupus nephritis that hasn't responded to st…
Phase 1/2 • Sponsor: Kyverna Therapeutics • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a daily pill help people with type 2 diabetes shed weight?
Disease control Stopped earlyThis phase 2 trial tests whether LY3549492, an oral tablet, helps adults who are overweight or obese and have type 2 diabetes lose weight. Participants receive either LY3549492 or a placebo for about 11 months. Researchers measure changes in body weight and the percentage of peop…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could diabetes pills replace insulin shots in hospitals?
Disease control Stopped earlyThis study compares continuing oral diabetes medications (like metformin) versus switching to insulin in hospitalized adults with type 2 diabetes. About 255 participants will be randomly assigned to either stay on their usual pills or receive insulin injections. The goal is to se…
Phase 4 • Sponsor: Emory University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Radioactive drug targets Hard-to-Treat melanoma in early trial
Disease control Stopped earlyThis early-stage trial tests a radioactive drug called [225Ac]Ac-A9-3408 in 50 adults with melanoma that has spread or can't be removed by surgery. The main goals are to find a safe dose and check for side effects. Participants receive the drug every 6 weeks for up to 6 doses, an…
Phase 1 • Sponsor: Alpha-9 Oncology USA Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Experimental drug aims to save Insulin-Making cells in newly diagnosed type 1 diabetes
Disease control Stopped earlyThis Phase 2 trial tested an oral drug called ladarixin in 141 people aged 14-45 recently diagnosed with type 1 diabetes. The goal was to see if ladarixin could preserve the body's ability to produce insulin by protecting beta cells. The study was terminated early, so while it ma…
Phase 2 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Experimental CAR-T therapy takes on Hard-to-Treat lupus nephritis
Disease control Stopped earlyThis early-phase trial is testing a personalized cell therapy called KYV-101 for people with lupus nephritis that hasn't responded to standard treatments. The therapy uses a patient's own immune cells, modified to target and destroy faulty B cells that drive the disease. Only 2 p…
Phase 1/2 • Sponsor: Kyverna Therapeutics • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Which eczema drug wins? a Head-to-Head test aims to find out
Disease control Stopped earlyThis trial compares two approved eczema drugs, upadacitinib and dupilumab, in people with moderate-to-severe atopic dermatitis. Researchers will measure how well each drug clears the skin and improves quality of life, including itch and sleep. The study aims to confirm earlier fi…
Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can an antiviral drug protect hearing in infants with congenital CMV?
Disease control Stopped earlyThis trial tests whether the antiviral drug valganciclovir can improve hearing and language outcomes in infants who have hearing loss due to congenital cytomegalovirus (CMV) infection. Infants aged 1 to 12 months with confirmed sensorineural hearing loss will receive either valga…
Phase 2 • Sponsor: Albert Park • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Halted gene therapy study raises questions for AMN patients
Disease control Stopped earlyThis early-stage trial tested a gene therapy called SBT101 for adrenomyeloneuropathy (AMN), a rare nerve disease that causes walking difficulties. Eight adults received either the therapy or a sham procedure. The study was terminated early, so we have limited data on safety and e…
Phase 1/2 • Sponsor: SwanBio Therapeutics, Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New hope for recurring c. diff: which treatment works best?
Disease control Stopped earlyThis study tested three different antibiotic regimens for people with recurrent Clostridium difficile infection (C. diff), a serious gut infection that keeps coming back. The goal was to see if newer drugs like fidaxomicin or a tapered/pulsed course of vancomycin work better than…
Phase 4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a less invasive valve replacement tame a failing aortic valve?
Disease control Stopped earlyThis study is a patient registry that collects information on people with severe aortic stenosis or aortic regurgitation who are treated with the Trilogy heart valve system, a device implanted via a catheter (TAVI) to replace the aortic valve without open-heart surgery. The goal …
Sponsor: JenaValve Technology, Inc. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could a seizure drug curb alcohol withdrawal in trauma wards?
Disease control Stopped earlyThis trial tests whether valproate, a medication used for epilepsy, can help prevent or ease alcohol withdrawal symptoms in heavy drinkers admitted to trauma care. Participants receive standard treatment with lorazepam (a benzodiazepine) as needed, and some also get valproate. Th…
Phase 4 • Sponsor: CAMC Health System • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Experimental antibody takes aim at eye inflammation
Disease control Stopped earlyThis study tests an experimental drug called REGN7041 in 72 people with active noninfectious uveitis, a condition causing inflammation inside the eye. The drug is an antibody designed to calm the immune system. Since this is the first time it's tested in humans, the main goal is …
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
PNH drug iptacopan tested in Real-World setting – but study cut short
Disease control Stopped earlyThis study looked at how well the drug iptacopan works for people with paroxysmal nocturnal hemoglobinuria (PNH) when used in everyday medical practice in Russia. Only 6 adults took part, and the study was terminated early. Researchers measured whether patients' hemoglobin levels…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a daily pill stop hereditary angioedema attacks?
Disease control Stopped earlyThis trial tests whether an experimental oral medication, deucrictibant, can reduce the number of swelling attacks in people with hereditary angioedema (HAE) types I and II. Participants take either a low or high dose of the drug or a placebo for 12 weeks, and then may continue o…
Phase 2 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can an inhaled protein save lungs in Alpha-1? new trial aims to find out
Disease control Stopped earlyThis study tests whether inhaling alpha-1 antitrypsin (AAT) daily can slow lung function loss in people with Alpha-1 deficiency and moderate-to-severe lung disease. 220 adults will receive either the drug or a placebo for two years, then all will receive the drug for two more yea…
Phase 3 • Sponsor: Kamada, Ltd. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a Blood-Cleansing combo tame deadly lung Flare-Ups?
Disease control Stopped earlyThis trial tests whether a combination of plasma exchange, rituximab, and intravenous immunoglobulins can improve survival in people hospitalized in intensive care with a severe acute exacerbation of idiopathic pulmonary fibrosis (IPF). IPF is a progressive lung disease, and thes…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a fluid from amniotic cells ease ankle arthritis pain?
Disease control Stopped earlyThis study tests whether a single injection of Axolotl Ambient, a fluid rich in growth factors derived from human amniotic cells, can reduce pain and improve function in people with ankle osteoarthritis. Participants will be randomly assigned to receive either the investigational…
Phase 1/2 • Sponsor: Axolotl Biologix • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Quitting before the knife: which Stop-Smoking aid works best for cancer patients?
Disease control Stopped earlyThis trial explores whether adding counseling, cognitive behavioural therapy, or hypnotherapy to nicotine replacement therapy can help cancer patients quit smoking before their surgery. The study includes adults with breast, digestive, gynecologic cancer, or melanoma who smoke da…
Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a cholesterol drug and a bile acid pill help reverse liver scarring?
Disease control Stopped earlyThis pilot study tests whether simvastatin (a cholesterol-lowering drug) and ursodeoxycholic acid (a bile acid medication), taken alone or together for six months, can improve markers of liver fibrosis in adults with advanced liver scarring after viral hepatitis has been controll…
Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a simple inhaled combo keep pneumonia patients off ventilators?
Disease control Stopped earlyThis phase 3 trial tests whether an inhaled combination of budesonide (a corticosteroid) and formoterol (a bronchodilator) can prevent acute respiratory failure in hospitalized adults with pneumonia and low blood oxygen levels. Participants receive either the active treatment or …
Phase 3 • Sponsor: Stanford University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Experimental MS drug tested in kids, but study halted early
Disease control Stopped earlyThis study tested the drug alemtuzumab in children aged 10 to 18 with relapsing-remitting multiple sclerosis (MS) whose disease was still active despite other treatments. The goal was to see if the drug could reduce new brain lesions and improve quality of life. However, the tria…
Phase 3 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Experimental antibody combo shows promise against tough cancers
Disease control Stopped earlyThis study tested a new antibody called ICT01 combined with low-dose interleukin-2 (IL-2) in 56 people with advanced solid tumors like colorectal, ovarian, and pancreatic cancer. The goal was to see if the combo is safe and can shrink tumors. Early results suggest it may help con…
Phase 1/2 • Sponsor: ImCheck Therapeutics, an Ipsen company • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Simple work advice may cut sick leave days, trial suggests
Disease control Stopped earlyThis trial tests whether a short vocational advice program helps people on sick leave return to work sooner. Adults who have been off work for at least two weeks due to health issues receive support from a trained worker to identify barriers and plan their return. The study compa…
Sponsor: Keele University • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
A common diabetes drug may protect against hormone therapy's metabolic side effects
Disease control Stopped earlyThis phase 3 trial tests whether metformin, a standard diabetes medication, can prevent or reverse metabolic syndrome in men with prostate cancer who are starting androgen deprivation therapy (ADT). Metabolic syndrome—a cluster of conditions like high blood sugar, high blood pres…
Phase 3 • Sponsor: Canadian Urologic Oncology Group • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a better antidote stop opioid overdoses faster?
Disease control Stopped earlyThis study investigates how effectively two opioid antidotes—naloxone (given as a nasal spray or injection) and nalmefene (given as an injection)—can reverse dangerous breathing problems caused by strong opioids like fentanyl. The trial includes both healthy volunteers and people…
Phase 1 • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
A common supplement may shield bones in kidney disease — a trial puts it to the test
Disease control Stopped earlyThis pilot trial investigates whether potassium citrate can improve bone quality and strength in adults and children with chronic kidney disease. Participants take either potassium citrate or a placebo for six months, along with blood and urine tests and advanced bone scans. The …
Phase 2/3 • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could a new drug help preserve insulin production in type 1 diabetes?
Disease control Stopped earlyThis early-stage trial tested four different doses of siplizumab in 8 people aged 8–45 who were diagnosed with type 1 diabetes within the past 18 months. The goal was to find a safe dose that changes certain immune cell patterns linked to better insulin production. Participants r…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Psoriasis patients switch biologics in new Real-World study
Disease control Stopped earlyThis study watches 200 adults with moderate to severe psoriasis who switch from ustekinumab to guselkumab in everyday medical practice. Researchers track how well the new drug clears skin symptoms and check for side effects over 52 weeks. The goal is to see if guselkumab works sa…
Sponsor: Janssen-Cilag Ltd. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a once-weekly antibiotic help people with opioid use disorder beat serious infections at home?
Disease control Stopped earlyThis trial tests whether a weekly IV antibiotic called oritavancin, given alongside medication for opioid use disorder, can help people finish treatment for serious infections like bloodstream or bone infections without needing to stay in a nursing facility. The study enrolls adu…
Phase 4 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New thumb implant aims to ease arthritis pain
Disease control Stopped earlyThis study is testing a new thumb implant called the InDx CMC Implant for people with thumb arthritis. The implant replaces part of the thumb joint to improve hand function and reduce pain. Researchers will track safety and how well the implant works in 73 adults over time.
Sponsor: Loci Orthopaedics • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Rheumatoid arthritis combo drug trial stalls after just 2 patients
Disease control Stopped earlyThis early-stage trial tested whether adding an experimental drug called VIB4920 to standard TNF-inhibitor therapy could improve disease control in people with rheumatoid arthritis. Only 2 participants were enrolled before the study was terminated, so no meaningful conclusions ca…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Brain training: behavioral therapy may rewire social circuits in autistic toddlers
Disease control Stopped earlyThis study investigates whether a 10-week behavioral intervention called JASPER can improve early communication skills and alter brain activity in toddlers and preschoolers with autism. Participants aged 18 to 59 months receive twice-weekly sessions focused on joint attention and…
Sponsor: Boston University Charles River Campus • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New eczema drug shows promise in Long-Term safety trial for thousands
Disease control Stopped earlyThis study looks at the long-term safety and tolerability of a drug called rocatinlimab for people with moderate-to-severe atopic dermatitis (eczema). It involves over 2,600 adults and teenagers who have already completed a previous rocatinlimab study. Researchers will monitor si…
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can virtual coaching close the autism care gap for black toddlers?
Disease control Stopped earlyThis trial tests whether a telehealth-based family navigation program helps Black toddlers under age 4 start autism-specific intervention faster after diagnosis. Families in the program receive up to four virtual sessions with a trained navigator who helps them find and enroll in…
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could earlier testing for pregnancy diabetes prevent complications?
Disease control Stopped earlyThis trial investigates whether screening for gestational diabetes earlier in pregnancy (at 18-20 weeks instead of the usual 24-28 weeks) and providing prompt lifestyle advice and medication if needed can reduce complications such as large babies, C-sections, and high blood press…
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could less be more? shorter antibiotic course after appendix surgery put to the test
Disease control Stopped earlyThis trial compares two approaches to antibiotic use after appendix removal surgery: a restrictive course (none or up to 24 hours) versus a liberal course (24 hours to 4 days). The goal is to see if the shorter course is just as safe and effective, while reducing side effects and…
Phase 4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for painful skin condition: brensocatib enters phase 2b trial
Disease control Stopped earlyThis study tests whether brensocatib can reduce painful lumps and abscesses in people with moderate to severe hidradenitis suppurativa (HS). About 214 adults will receive either brensocatib or a placebo for 16 weeks. The goal is to see if the drug improves skin lesions and overal…
Phase 2 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Placenta cells tested as COVID fighter – but trial stopped early
Disease control Stopped earlyThis early-phase trial tested a new therapy called CYNK-001, which uses natural killer cells from the placenta to fight COVID-19. It enrolled only 7 adults with moderate COVID-19. The study was terminated early, so we have limited information on safety and effectiveness.
Phase 1/2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug shows promise for Long-Term control of ulcerative colitis
Disease control Stopped earlyThis study looks at the long-term safety of brazikumab, a drug given as a shot every 4 weeks, for people with moderate to severe ulcerative colitis. Participants had already taken part in an earlier study of brazikumab. The goal is to see if the drug remains safe over a longer pe…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Experimental achondroplasia drug trial halted early
Disease control Stopped earlyThis study tested an experimental drug called SAR442501 in children with achondroplasia, a common form of dwarfism. The goal was to see if the drug was safe and could improve growth. However, the trial was stopped early after enrolling only 16 children, so we have very little inf…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Alzheimer's drug ALZ-801 tested Long-Term in High-Risk group
Disease control Stopped earlyThis study looked at the long-term safety and effects of ALZ-801, a tablet taken twice daily, in 163 people with early Alzheimer's disease who have the APOE4/4 gene. Participants had already completed a previous phase 3 study. The goal was to see if the drug could slow cognitive …
Phase 3 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug brazikumab aims to tame ulcerative colitis Flare-Ups
Disease control Stopped earlyThis phase 2 trial tested brazikumab in 242 adults with moderate-to-severe ulcerative colitis. Participants received either brazikumab or a placebo intravenously and then as injections over 54 weeks. The goal was to see if the drug could improve symptoms and heal the colon lining…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Heart valve study halted early: which blood thinner is safer?
Disease control Stopped earlyThis study compared two antiplatelet drug regimens after transcatheter aortic valve implantation (TAVI) for aortic stenosis. One group received ticagrelor alone, the other received aspirin plus clopidogrel. The goal was to see which caused fewer serious complications like bleedin…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can IBD patients safely stretch their infusion schedule? new study tests two strategies
Disease control Stopped earlyThis study looks at people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who are in deep remission. It compares two methods for gradually increasing the time between infliximab infusions: one based on symptoms and one based on drug levels in the blood. T…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Personalized interferon therapy aims to tame kidney disease without weakening defenses
Disease control Stopped earlyThis phase 2 trial investigates whether a personalized course of peginterferon alfa-2a can control membranous nephropathy, an autoimmune kidney disease. The treatment targets the Th17 inflammatory pathway, which is linked to a higher risk of relapse. Participants receive injectio…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental bone putty for spinal surgery falls short in early trial
Disease control Stopped earlyThis study tested a special bone graft material (MatriBONE mixed with the patient's own bone marrow) for spinal fusion surgery in people with painful degenerative back problems. The goal was to see how well the bones fused together after 12 months. However, the trial was stopped …
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a glucose monitor boost diabetes education for newly diagnosed patients?
Disease control Stopped earlyThis study tested whether using a Freestyle Libre 2 continuous glucose monitor for 28 days, along with standard therapeutic education, helps people recently diagnosed with type 2 diabetes improve their blood sugar control. The trial enrolled 27 adults diagnosed within the past ye…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Eczema drug study halted early: what we learned about GSK1070806
Disease control Stopped earlyThis study was designed to check the long-term safety of an experimental drug called GSK1070806 for people with moderate to severe eczema (atopic dermatitis). It enrolled 79 adults who had already completed an earlier study of the same drug. The study was terminated early, so res…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Tooth-Related sinusitis study halted early – results uncertain
Disease control Stopped earlyThis study looked at whether treating the dental cause of chronic maxillary sinusitis with dental procedures and medication could resolve symptoms. Only 16 patients were enrolled before the study was terminated. The main goal was to see if symptoms disappeared and pus cleared fro…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could ditching heparin during heart valve repair cut bleeding risks?
Disease control Stopped earlyThis trial tests whether performing balloon aortic valvuloplasty without the blood thinner heparin reduces serious bleeding and blood vessel complications. About 94 adults with severe, symptomatic aortic stenosis will be randomly assigned to receive either heparin or a placebo du…
Phase 4 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
CBD shows promise for alcohol use disorder in early trial
Disease control Stopped earlyThis phase 2 trial tested whether cannabidiol (CBD), a non-psychoactive compound from cannabis, could help people with alcohol use disorder reduce their drinking. The study also looked at whether CBD could protect the brain and liver from alcohol's harmful effects. Only 10 people…
Phase 2 • Sponsor: Hôpital le Vinatier • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New proton therapy aims to save eyes from removal in large melanoma cases
Disease control Stopped earlyThis study tested two different proton therapy schedules for people with large choroidal melanomas (eye cancer) that would normally require removal of the eye. The goal was to see if a gentler radiation schedule could control the tumor and avoid severe side effects, allowing pati…
Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Experimental drug targets stubborn cholesterol in rare disease
Disease control Stopped earlyThis study tested an experimental drug called ARO-ANG3 in 18 people with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol. Participants received injections of the drug and were monitored for safety and cholesterol change…
Phase 2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Promising depression relapse prevention drug study halted early
Disease control Stopped earlyThis study tested whether adding the drug aticaprant to standard antidepressants could prevent depression from returning in people with major depressive disorder who also experience a loss of interest or pleasure (anhedonia). The study enrolled 47 adults who had responded well to…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Heart drug fails to prove benefit for lung failure patients in early-stop trial
Disease control Stopped earlyThis study tested whether giving the heart medication metoprolol through a vein could help people with severe lung failure (ARDS) in the ICU. The goal was to see if it helped them breathe without a machine for more days. However, the trial was stopped early and only 14 people too…
Phase 3 • Sponsor: Consorcio Centro de Investigación Biomédica en Red (CIBER) • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Eczema drug trial halted midway – what happened?
Disease control Stopped earlyThis study tested an injectable drug called GSK1070806 in 161 adults with moderate to severe atopic dermatitis (eczema) who had already tried other treatments. The goal was to see if the drug could reduce eczema severity and itching compared to a placebo. However, the trial was t…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can early speech therapy boost language in preterm babies?
Disease control Stopped earlyThis study tested an early speech therapy program for children born very prematurely or with severe growth restriction. The program involved 10 to 20 sessions with a trained speech therapist from 6 to 24 months of age. The goal was to see if it could reduce language and communica…
Sponsor: Centre Hospitalier Sud Francilien • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Heart drug study halted early: what we know
Disease control Stopped earlyThis study tested an experimental drug called CRD-4730 in people with a rare inherited heart rhythm disorder (CPVT) that can cause dangerous fast heartbeats. Seven adults received two different doses of the drug and a placebo to check safety and how the body processes it. The stu…
Phase 2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Hospital hep c treatment aims to cure drug users
Disease control Stopped earlyThis study tested giving hepatitis C treatment to people who inject drugs while they were already in the hospital for other infections. The goal was to cure their hepatitis C and make sure they stayed connected to care afterward. The study was stopped early, but it included 21 pa…
Sponsor: Kirby Institute • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Rheumatoid arthritis drug study halted early – what we know
Disease control Stopped earlyThis study tested an experimental drug called GS-0272 in adults with rheumatoid arthritis to see if it is safe and how the body processes it. The trial was stopped early, so results are limited. About 55 people were planned to take part, receiving either the drug or a placebo.
Phase 1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Probiotics and brushing: a tiny study on gum health in teens with braces ends early
Disease control Stopped earlyThis study looked at whether taking probiotic tablets (Lactobacillus reuteri) twice a day, along with regular tooth brushing, could reduce gum inflammation in teenagers with braces. Only 3 participants were enrolled before the study was terminated early, so no meaningful results …
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Experimental diabetes drug trial halted early
Disease control Stopped earlyThis study tested an experimental drug called TOL-3021 in people with type 1 diabetes to see if it could help preserve the body's ability to produce insulin. The trial enrolled 78 participants aged 12 to 41 who had been diagnosed within the last 5 years. The study was terminated …
Phase 2 • Sponsor: Tolerion, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Shorter antibiotics after appendectomy may be just as effective
Disease control Stopped earlyThis study looked at whether giving antibiotics for a shorter time after appendix removal works as well as a longer course. It included adults with simple or complex appendicitis. The goal was to see if shorter treatment could reduce side effects and still cure the infection.
Sponsor: University of Louisville • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Promising diabetes delay study halted due to lack of participants
Disease control Stopped earlyThis study tested a low dose of a drug called ATG to see if it could delay or prevent type 1 diabetes in people at high risk. Only 2 people enrolled, so the study was stopped early. The goal was to measure how long it took for participants to develop full-blown diabetes.
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Shorter antibiotic course after heart surgery for IV drug users shows promise
Disease control Stopped earlyThis study looked at whether people who had heart surgery for endocarditis (a serious heart infection) related to IV drug use could safely switch from IV antibiotics to oral pills after just two weeks. The goal was to see if this shorter hospital stay was safe and effective. The …
Phase 4 • Sponsor: West Virginia University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Old allergy drug may help repair nerves in MS patients
Disease control Stopped earlyThis study tested whether clemastine fumarate, an allergy medication, could improve eye movement problems in people with multiple sclerosis (MS). The trial planned to enroll 80 MS patients with a specific eye condition called internuclear ophthalmoparesis, but was terminated earl…
Phase 3 • Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New daily pill aims to stop HAE attacks, but trial cut short
Disease control Stopped earlyThis phase 2 trial tested KVD824, an oral pill, to prevent swelling attacks in people with hereditary angioedema types I and II. The study planned to compare three doses against a placebo over several months. However, the trial was terminated early with only 33 participants, so t…
Phase 2 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Experimental liver drug INT-787 studied for severe alcohol hepatitis
Disease control Stopped earlyThis study tested a drug called INT-787 in 67 people with severe alcohol-associated hepatitis, a serious liver condition. The trial was a phase 2a proof-of-concept study, but it was terminated early. Researchers were looking at safety, how well the drug works, and how the body pr…
Phase 2 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Hydroxychloroquine trial for rare vasculitis halted early
Disease control Stopped earlyThis study tested whether hydroxychloroquine, a drug used for lupus and arthritis, could help control ANCA vasculitis—a group of autoimmune diseases that cause blood vessel inflammation. Adults with mild disease activity were randomly assigned to receive hydroxychloroquine or a p…
Phase 4 • Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Phone Check-Ins tested to keep anorexia patients on track after hospital
Disease control Stopped earlyThis study tested whether regular phone calls after a first hospital stay for anorexia nervosa could help patients maintain a healthy weight and avoid relapse. Researchers planned to compare phone-based support to standard follow-up care in people over 15. The study was terminate…
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Experimental pill aims to stop extra bone growth in rare disease
Disease control Stopped earlyThis phase 2 trial tested two doses of an oral drug called fidrisertib (IPN60130) in children and adults with fibrodysplasia ossificans progressiva (FOP), a rare condition where soft tissues turn into bone. The goal was to see if the drug could reduce new abnormal bone growth com…
Phase 2 • Sponsor: Clementia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Diabetes drug adherence study halted after just one participant
Disease control Stopped earlyThis study aimed to see if following the exact dosing instructions for oral semaglutide helps control blood sugar in people with type 2 diabetes who are already on metformin. Only one person enrolled before the study was stopped early. The main focus was on changes in blood sugar…
Sponsor: Aalborg University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Radiation boosts immunotherapy in melanoma? small trial halted early
Disease control Stopped earlyThis phase II trial tested whether adding radiotherapy to the immunotherapy drug pembrolizumab could better control advanced melanoma than pembrolizumab alone. Only 17 people took part before the study was stopped early. The goal was to see if radiation could trigger an 'abscopal…
Phase 2 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Kidney-Liver drug trial halted early – what happened?
Disease control Stopped earlyThis small Phase 2 study tested two doses of vonafexor, an oral drug, in 10 people with mild-to-moderate chronic kidney disease and suspected MASH (a type of fatty liver disease). The goal was to see if vonafexor could improve kidney function. However, the trial was terminated ea…
Phase 2 • Sponsor: Enyo Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Experimental KRRO-110 trial for rare lung condition halted early
Disease control Stopped earlyThis study tested an experimental drug called KRRO-110 in healthy volunteers and people with Alpha-1 Antitrypsin Deficiency (AATD), a genetic condition that can cause lung and liver damage. The goal was to check safety and how the drug moves through the body. However, the trial w…
Phase 1/2 • Sponsor: Korro Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Stem cells tested for tough bowel disease – but trial stopped early
Disease control Stopped earlyThis early-stage study tested whether injecting donor stem cells (remestemcel-L) into the colon could help people with severe ulcerative colitis that hadn't responded to other treatments. Only 7 adults took part before the trial was stopped early. The main goal was to check safet…
Phase 1/2 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Stem cell shot aims to heal painful Crohn's fistulas
Disease control Stopped earlyThis early-stage study tested whether injecting donor stem cells directly into fistulas (abnormal tunnels) could help people with Crohn's disease. The trial planned to enroll 25 adults but was terminated early. The goal was to check safety and see if the treatment could lead to c…
Phase 1/2 • Sponsor: Anthony Lembo • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Depression drug aticaprant safety trial halted early
Disease control Stopped earlyThis study tested the long-term safety of a drug called aticaprant when added to a standard antidepressant for adults with major depression. The trial planned to enroll 871 people but was terminated early, so the full safety and effectiveness data are not available. Researchers w…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a common cholesterol drug protect bones and hearts after spinal injury?
Disease control Stopped earlyThis study tested whether the statin drug rosuvastatin, taken daily with supplements, could improve bone density and reduce heart disease risk in adults with long-term spinal cord injury. Only 8 people enrolled before the trial was stopped early. Participants received either rosu…
Phase 2 • Sponsor: Dr. B. Catharine. Craven • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Experimental gene therapy targets rare immune disorder
Disease control Stopped earlyThis trial tested a gene therapy for X-linked chronic granulomatous disease (X-CGD), a rare genetic disorder that leaves boys unable to fight off infections. The treatment involved taking the patient's own blood stem cells, adding a working copy of the faulty gene, and returning …
Phase 1/2 • Sponsor: Genethon • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental pill for alcoholism hits roadblock: trial terminated
Disease control Stopped earlyThis phase 2 study tested a drug called TMP-301 in 110 adults with alcohol use disorder to see if it is safe and helps reduce drinking. Participants took TMP-301 or a placebo daily for 14 weeks. The trial was terminated early, so we don't have clear results on whether the drug wo…
Phase 2 • Sponsor: Tempero Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Alzheimer's drug trial halted early after only 8 volunteers
Disease control Stopped earlyThis study tested a drug called PrimeC in people with mild to moderate Alzheimer's disease. The goal was to see if it is safe and if it helps with thinking and daily activities. The study was stopped early and only 8 people took part, so results are very limited.
Phase 2 • Sponsor: NeuroSense Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Promising liver drug trial halted early: what it means for patients
Disease control Stopped earlyThis study tested a new drug called belcesiran in people with a genetic condition called alpha-1 antitrypsin deficiency that causes liver damage. The goal was to see if the drug is safe and can lower harmful protein levels in the liver. The trial was stopped early, so results are…
Phase 2 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
HIV and opioid treatment study halted early – what we know
Disease control Stopped earlyThis study looked at whether different medications for opioid use disorder (methadone, buprenorphine/naloxone, or naltrexone) could reduce immune system inflammation in people with HIV. Researchers measured changes in blood markers of immune activation over 24 weeks. The trial wa…
Phase 2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
HIV pill combo fails to slim belly fat in early trial
Disease control Stopped earlyThis study tested whether switching to a two-drug HIV treatment (raltegravir plus maraviroc) could reduce belly fat (lipohypertrophy) in people whose HIV was already well-controlled. It included 48 adults on stable HIV therapy for at least 5 years. The study was stopped early, so…
Phase 2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Knee osteoarthritis drug trial halted early – what we know
Disease control Stopped earlyThis study tested an experimental drug called LNA043, given as injections into the knee, to see if it could slow cartilage loss and reduce pain in people with knee osteoarthritis. The trial planned to follow 576 participants for up to 5 years, but it was terminated early. The mai…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Growth hormone study for short kids halted early
Disease control Stopped earlyThis study looked at two ways of giving growth hormone to short children who were born small for their age. The goal was to see which dosing method works better for growth and has fewer side effects on metabolism. Only 10 children took part before the study was stopped early.
Phase 4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Alzheimer's Tau-Targeting antibody trial halted midway
Disease control Stopped earlyThis study tested an experimental antibody called JNJ-63733657 in 523 people with early Alzheimer's disease. The antibody aims to clear tau protein clumps in the brain, which are linked to cognitive decline. Participants received either the antibody or a placebo by IV infusion. T…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could an arthritis drug tame giant cell arteritis?
Disease control Stopped earlyThis study tested whether adding anakinra, an anti-inflammatory drug, to standard steroid treatment could lower relapse rates in people with giant cell arteritis, a blood vessel disease. The trial planned to include 70 adults over 50 but was stopped early with only 30 participant…
Phase 3 • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug aims to tame hard-to-control seizures in rare mitochondrial disorders
Disease control Stopped earlyThis study tested a drug called vatiquinone in 68 people with mitochondrial disease and epilepsy that doesn't respond to standard treatments. Participants were randomly assigned to receive either vatiquinone or a placebo for 24 weeks to see if the drug could reduce the number of …
Phase 2/3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
CBD-Hydroxychloroquine combo tested for arthritis pain – but trial ends early
Disease control Stopped earlyThis study tested a combination pill called IHL-675A, which contains cannabidiol (CBD) and hydroxychloroquine, in people with rheumatoid arthritis. The goal was to see if it safely reduces pain and improves daily function. The trial planned to enroll 128 volunteers but was termin…
Phase 2 • Sponsor: Incannex Healthcare Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Promising psoriasis drug trial halted early – what now?
Disease control Stopped earlyThis study tested a drug called imsidolimab for adults with generalized pustular psoriasis (GPP), a rare and painful skin condition. The trial aimed to see if the drug is safe and works over the long term. However, the study was terminated early, so we have less information than …
Phase 3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a simple gas stop COVID-19 from getting worse?
Disease control Stopped earlyThis study tested whether breathing in nitric oxide gas could keep mild-to-moderate COVID-19 from becoming severe. Researchers enrolled 62 hospitalized adults who were breathing on their own. The goal was to see if the gas reduced the need for a breathing tube. The trial was stop…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a steroid spray break the decongestant habit?
Disease control Stopped earlyThis small, early-stage trial tested a combination of a steroid spray (triamcinolone) and a decongestant spray (oxymetazoline) to help people who were dependent on decongestants stop using them. The study planned to slowly reduce the decongestant dose while keeping the steroid st…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New approach aims to protect new Moms' brains after preeclampsia
Disease control Stopped earlyThis study tested a new way to manage blood pressure in new mothers with severe postpartum preeclampsia. Participants received standard blood pressure medications, but one group had personalized blood pressure targets based on real-time brain monitoring. The goal was to keep bloo…
Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Plant-Based diet shows promise for diabetes remission in new study
Disease control Stopped earlyThis study looked at whether a plant-based diet and lifestyle changes could help people with type 2 diabetes, prediabetes, or obesity improve their health. Researchers aimed for diabetes remission (normal blood sugar without medication for at least 3 months) or significant weight…
Sponsor: National Council of Scientific and Technical Research, Argentina • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Obesity drug cocktail tested for heart benefits – study halted early
Disease control Stopped earlyThis study looked at whether using a combination of weight-loss medications could help people with obesity lose weight and improve the health of their blood vessels. It involved 128 adults aged 40-75 who were obese and had at least one heart risk factor. The study was stopped ear…
Phase 2 • Sponsor: University of Iowa • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Brain steroid injection tested for Alzheimer's – but trial halted early
Disease control Stopped earlyThis early study tested a weekly injection of allopregnanolone, a natural brain steroid, in 6 people with early Alzheimer's or mild cognitive impairment. The goal was to find a safe dose and check for side effects. The trial was terminated early, so we have limited information on…
Phase 1 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Cancer drug imatinib tested for rare eye melanoma – but trial stops early
Disease control Stopped earlyThis phase II trial tested the drug imatinib in 13 adults with metastatic ocular melanoma, a rare eye cancer that has spread. The goal was to see if imatinib could stop tumor growth for at least 3 months. The trial was terminated early, so the results are limited and it is unclea…
Phase 2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Fish oil fails to deliver in nerve damage trial
Disease control Stopped earlyThis study tested whether high-dose fish oil supplements could improve nerve function in people with prediabetes and early diabetic neuropathy. Researchers planned to enroll 40 adults aged 55–80, but the trial was terminated early with only 31 participants. Participants took eith…
Sponsor: University of Missouri-Columbia • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New Three-Drug cocktail takes on tough melanoma
Disease control Stopped earlyThis study tested whether a three-drug combination (encorafenib, binimetinib, and pembrolizumab) works better than a two-drug combo (ipilimumab and nivolumab) for people with advanced melanoma that has a BRAF mutation and has already been treated with anti-PD-1 therapy. The trial…
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Tailored cancer cocktail tested for tough childhood tumor
Disease control Stopped earlyThis trial tested a personalized approach for children with relapsed or hard-to-treat neuroblastoma. Doctors used a tumor biopsy to find genetic changes and then assigned a combination of targeted drugs (ceritinib and ribociclib) to match those changes. The study was terminated e…
Phase 1 • Sponsor: Yael P Mosse • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Experimental CAR T-Cell therapy targets rare B-Cell cancers
Disease control Stopped earlyThis phase 2 study tested a treatment called brexucabtagene autoleucel, a CAR T-cell therapy made from a patient's own immune cells, for four rare B-cell cancers: Waldenstrom macroglobulinemia, Richter transformation, Burkitt lymphoma, and hairy cell leukemia. The trial enrolled …
Phase 2 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Eye infection breakthrough: new trial tests antivirals to save sight
Disease control Stopped earlyThis study compared two antiviral medicines (oral valganciclovir and topical ganciclovir 2%) against a placebo for treating CMV-related inflammation in the front of the eye. The goal was to see which approach better controls the infection and reduces complications like pain, glau…
Phase 2/3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Can a common diabetes drug shield transplanted kidneys?
Disease control Stopped earlyThis study tested the drug empagliflozin (a diabetes medicine) in 20 people who had a kidney transplant, some with type 2 diabetes and some without. The goal was to see if the drug could help protect their heart and kidney function. The trial was stopped early, so the findings ar…
Phase 2 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug shows promise for blistering skin disease in extended trial
Disease control Stopped earlyThis study looks at the long-term safety of a drug called efgartigimod for adults with moderate-to-severe bullous pemphigoid, a condition that causes painful blisters. Participants who finished the main study can continue treatment for up to 48 weeks, with the option to pause and…
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New tech approach aims to prevent repeat hospital stays for diabetes patients
Disease control Stopped earlyThis study tested whether a team-based approach using continuous glucose monitors could help adults with type 1 diabetes better control their blood sugar and avoid another hospital stay after a diabetic ketoacidosis (DKA) episode. Only 2 people enrolled before the study was stopp…
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Gel that promises faster healing after tooth extraction falls short in early trial
Disease control Stopped earlyThis study tested a gel made from hyaluronic acid and amino acids (Gumblast) to see if it helps surgical wounds in the mouth heal better. It involved 28 adults who needed at least two teeth extracted, with one socket treated with the gel and the other left to heal normally. The t…
Sponsor: The Wave Innovation Group s.r.l. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Virtual coaching for toddlers with autism shows promise but trial cut short
Disease control Stopped earlyThis study tested a completely virtual early intervention program for toddlers with autism, using telehealth coaching to help parents embed learning into daily activities. Researchers planned to enroll 240 children from eight US regions, but the trial was terminated early with on…
Sponsor: Florida State University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Experimental drug targets Hard-to-Treat cancers, but trial ends early
Disease control Stopped earlyThis study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer and other solid tumors that stopped responding to standard treatments. The goal was to see if the drug could shrink tumors or slow cancer growth. The trial was terminat…
Phase 2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Lupus kidney drug for teens shows promise, but trial cut short
Disease control Stopped earlyThis study tested a drug called voclosporin in teenagers with lupus nephritis, a kidney disease caused by lupus. The goal was to see if it could improve kidney function better than a placebo. Only 9 teens took part before the study was stopped early, so we don't have clear answer…
Phase 3 • Sponsor: Aurinia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Lupus kidney drug tested in kids – but study stopped early
Disease control Stopped earlyThis study looked at the long-term safety of the drug voclosporin in adolescents and children with lupus nephritis, a kidney disease caused by lupus. Participants took voclosporin capsules twice daily along with standard medications. The trial was terminated early and only enroll…
Phase 3 • Sponsor: Aurinia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New program aims to improve dental care in schizophrenia patients
Disease control Stopped earlyThis study tested a dental health education program for people with schizophrenia to see if it could improve their oral hygiene and quality of life. Participants were randomly assigned to either the education program or standard monitoring. The study lasted 12 months and included…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Promising cancer combo trial halted after just 2 patients
Disease control Stopped earlyThis early-phase study tested a radioactive drug called 225Ac-SSO110 combined with standard immune checkpoint inhibitors for people with advanced small cell lung cancer or Merkel cell carcinoma. The goal was to check safety and find the right dose. However, the trial was terminat…
Phase 1/2 • Sponsor: Ariceum Therapeutics GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can a smartphone app with rewards boost opioid treatment success after an emergency?
Disease control Stopped earlyThis study tested a mobile app that uses rewards to encourage people with opioid use disorder to start and stick with medication-assisted treatment after an emergency room visit. 41 adults from two hospitals were given access to the app for 12 weeks. The goal was to see if the ap…
Sponsor: Q2i, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Diabetes drug liraglutide may fight fatty liver, but trial halted early
Disease control Stopped earlyThis study looked at whether liraglutide, a diabetes drug, can reduce liver fat and improve cholesterol in people with type 2 diabetes. It involved 127 patients who took liraglutide for 6 months, with liver fat measured by MRI. However, the trial was terminated early, so the full…
Phase 4 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New COPD inhaler Add-On studied, but trial halted early
Disease control Stopped earlyThis study tested two doses of an inhaled drug called CHF6001 (Tanimilast) added to standard triple therapy in people with severe COPD and chronic bronchitis. The goal was to see if it could reduce the number of moderate or severe flare-ups over a year. The trial was terminated e…
Phase 3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Gut bacteria swap explored as MS treatment in early trial
Disease control Stopped earlyThis early-phase study tested whether a fecal transplant from a healthy donor could be safe and affect the immune system in people with relapsing-remitting multiple sclerosis. Only 5 participants were enrolled before the study was stopped. The goal was to see if changing gut bact…
Phase 1 • Sponsor: Jeffrey Gelfand • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a cancer drug tame rare overgrowth disease?
Disease control Stopped earlyThis early-phase trial tested taselisib, a drug that blocks a faulty protein causing excessive growth in people with PIK3CA-related overgrowth. Nineteen participants took the drug daily for four weeks to see if it was safe and tolerable. The study was stopped early, so we have li…
Phase 1/2 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Experimental vaccine combo for rare adrenal cancers shows early promise but trial halted
Disease control Stopped earlyThis early-phase trial tested a new therapeutic vaccine (EO2401) combined with the immunotherapy drug nivolumab in 70 people with advanced adrenocortical carcinoma or malignant pheochromocytoma/paraganglioma. The goal was to see if the combination is safe and can shrink tumors or…
Phase 1/2 • Sponsor: Enterome • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Hope fades: trial of Tay-Sachs drug venglustat terminated early
Disease control Stopped earlyThis Phase 3 trial tested an oral drug called venglustat in 75 adults and children with late-onset Tay-Sachs or Sandhoff disease, rare genetic disorders that cause progressive nerve damage. The drug aimed to lower toxic fat buildup in the brain and slow disease worsening. However…
Phase 3 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Old arthritis drug tested against rare tumor syndrome – but trial stalls
Disease control Stopped earlyThis study tested leflunomide, a drug used for rheumatoid arthritis, in 3 adults with MEN1 syndrome—a genetic condition that raises the risk of multiple tumors. The goal was to see if 6 months of daily leflunomide could shrink or stabilize tumors. However, the trial was terminate…
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental drug ravulizumab tested for kidney inflammation
Disease control Stopped earlyThis Phase 2 study tested the drug ravulizumab (Ultomiris) in 123 adults with lupus nephritis or IgA nephropathy, two conditions that cause kidney inflammation. Participants received either ravulizumab or a placebo alongside standard care. The study aimed to see if the drug could…
Phase 2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Experimental hepatitis b drug shows promise in early trial
Disease control Stopped earlyThis study tested a new drug called ARC-520 in 79 people with chronic hepatitis B. Some participants received ARC-520 alone, while others got it combined with standard treatments like entecavir or tenofovir. The goal was to see if ARC-520 could lower hepatitis B surface antigen l…
Phase 2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Immunotherapy duo shows promise in stopping melanoma return
Disease control Stopped earlyThis study tested whether combining two immunotherapy drugs (nivolumab and relatlimab) works better than nivolumab alone to keep melanoma from returning after surgical removal. It involved over 1,000 adults and teens with stage III or IV melanoma that had been completely removed.…
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Vitamin-Like supplement tested for diabetic nerve pain – but trial stopped early
Disease control Stopped earlyThis early-phase trial tested whether nicotinamide riboside (a form of vitamin B3 sold as Niagen) could help repair nerve damage in people with type 2 diabetes or prediabetes. Only 10 participants were enrolled before the study was terminated. The main goal was to measure changes…
Phase 1/2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Real-World tofacitinib study in ulcerative colitis ends early
Disease control Stopped earlyThis study looked at how well the drug tofacitinib (Xeljanz) works for people with moderate to severe ulcerative colitis in everyday medical practice in Switzerland. It measured symptom improvement and gut inflammation using stool samples. The study was small with 18 participants…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Experimental antibody trial for rare heart disease halted early
Disease control Stopped earlyThis phase 3 study tested an experimental drug called birtamimab in 208 people with advanced AL amyloidosis, a rare disease where abnormal proteins damage organs like the heart. Participants received either birtamimab or a placebo, plus standard chemotherapy. The goal was to see …
Phase 3 • Sponsor: Prothena Biosciences Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
COPD drug trial halted: new Add-On therapy falls short
Disease control Stopped earlyThis study tested an inhaled drug called CHF6001 (Tanimilast) in people with COPD and chronic bronchitis who were already on triple therapy. The goal was to see if adding this drug could reduce flare-ups. The trial was stopped early and involved about 4,700 participants.
Phase 3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Alzheimer's drug trial halted early – what we know
Disease control Stopped earlyThis study tested a drug called varoglutamstat (PQ912) in people with early Alzheimer's disease. The goal was to see if it is safe and if it could slow memory and thinking problems. The trial was stopped early, so we have less information than planned. About 112 people took part,…
Phase 2 • Sponsor: Vivoryon Therapeutics N.V. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Hizentra shows promise for rare muscle and skin disease
Disease control Stopped earlyThis study tested a medicine called Hizentra (IgPro20) in 134 adults with dermatomyositis, a rare disease causing muscle weakness and skin rashes. The goal was to see if weekly shots under the skin could improve symptoms better than a placebo. The study was stopped early, but res…
Phase 3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New pill for eczema shows promise in early trial – but study halted
Disease control Stopped earlyThis study tested an oral medication called SAR444656 in 70 adults with moderate to severe atopic dermatitis (eczema) that was not well controlled with topical treatments. Participants received one of three doses of the drug or a placebo for 16 weeks. The goal was to see if the d…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Polio Survivors' hope dashed: trial of immune treatment halted early
Disease control Stopped earlyThis study tested a blood product called immune globulin (Flebogamma) in 191 people with post-polio syndrome, a condition causing new muscle weakness years after polio. The goal was to see if it could improve walking distance and reduce pain. The trial was terminated early, so we…
Phase 2/3 • Sponsor: Instituto Grifols, S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New dialysis device for Wilson's disease tested but trial stopped early
Disease control Stopped earlyThis trial tested a special dialysis device (MEX-CD1) designed to remove extra copper from the blood of people with Wilson's disease, a genetic condition that causes copper buildup. The study planned to give 5 to 10 treatments over consecutive days and check if the device worked …
Sponsor: Mexbrain • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug peresolimab tested for rheumatoid arthritis – study ends early
Disease control Stopped earlyThis study tested peresolimab, an experimental drug, in 491 adults with moderately-to-severely active rheumatoid arthritis who had not responded well to other treatments. The goal was to see if peresolimab could reduce joint pain and swelling better than a placebo. However, the s…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Bone drug tested to save knees after ACL injury – but trial stalls
Disease control Stopped earlyThis early study tested whether a single infusion of zoledronic acid, a drug used for osteoporosis, could improve bone health and slow joint damage after an ACL tear. Only 4 people were enrolled before the trial was terminated, so the results are very limited. The study aimed to …
Phase 1 • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a common cholesterol drug tame inflammatory bowel disease?
Disease control Stopped earlyThis study tested whether statins, a common cholesterol drug, could change the gut bacteria in people with ulcerative colitis or Crohn's disease to a healthier type. The goal was to see if this change could reduce disease activity. The study was terminated early, so results are l…
Phase 2/3 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Custom-grown ear implant tracked for long-term safety and looks
Disease control Stopped earlyThis study followed one person with microtia (a small or missing outer ear) who had already received an AUR-201 implant — a 3D-printed ear made from their own cartilage cells. Researchers checked how well the implant kept its shape and whether any side effects appeared up to 96 w…
Phase 1/2 • Sponsor: Auregen Biotherapeutics, SA • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
3D-Printed ear implant made from your own cells tested in tiny trial
Disease control Stopped earlyThis trial tested a new ear implant called AUR-201 for people with a rare birth defect called microtia, where one ear is small or missing. The implant was custom-made using the patient's own cartilage cells and a 3D-printed scaffold. Only 3 people were enrolled before the study w…
Phase 1/2 • Sponsor: Auregen Biotherapeutics, SA • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Psoriasis combo therapy trial ends early: what happened?
Disease control Stopped earlyThis study tested whether adding low-dose methotrexate to standard anti-TNF therapy could improve and extend the response in adults with moderate to severe psoriasis. The trial planned to enroll 78 participants but was terminated early. The main goal was to see how long patients …
Phase 4 • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Early scope procedure fails to show clear benefit in severe pancreatitis trial
Disease control Stopped earlyThis study tested whether doing an early endoscopic ultrasound and removing any gallstones from the bile duct could help people with severe pancreatitis caused by gallstones. The trial planned to enroll many patients but was stopped early after only 27 participants. The main goal…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Experimental ear implant tested in tiny study
Disease control Stopped earlyThis study tested an experimental implant called AUR-201 to rebuild the outer ear in people with unilateral microtia (one ear that is small or missing). Only 2 people enrolled before the study was stopped early. The goal was to check safety and see if the implant improved ear app…
Phase 1 • Sponsor: Auregen Biotherapeutics, SA • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Promising c. diff drug trial halted after just 3 patients
Disease control Stopped earlyThis study tested a new drug called REC-3964 to see if it could prevent repeat Clostridioides difficile (C. diff) infections in adults. Only 3 people were enrolled before the trial was stopped early. The goal was to check safety and whether the drug helped people stay infection-f…
Phase 2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Targeted drug shows promise for rare genetic cancers
Disease control Stopped earlyThis study tested a drug called niraparib in 22 adults with advanced solid tumors (like breast, lung, or pancreatic cancer) that have a specific genetic change called a PALB2 mutation. The goal was to see if the drug could shrink tumors or slow cancer growth. The study was stoppe…
Phase 2 • Sponsor: Tempus AI • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Experimental cell therapy targets deadly childhood brain cancer
Disease control Stopped earlyThis early-phase trial tested a new immunotherapy approach for children with DIPG, a rare and aggressive brain stem tumor. After standard radiation and chemotherapy, patients received special vaccines and immune cells designed to attack the tumor. The study was small (11 particip…
Phase 1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Schizophrenia drug trial cut short: only 34 of 250 patients enrolled
Disease control Stopped earlyThis study tested cariprazine (VRAYLAR), an approved schizophrenia drug in the U.S., for people with acute schizophrenia in Japan and Taiwan. Participants received either cariprazine or a placebo for 6 weeks, then could continue on cariprazine for 18 more weeks. The trial was ter…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Experimental drug targets rare fat Disorder's metabolic woes
Disease control Stopped earlyThis phase 2 trial tested a drug called REGN4461 (mibavademab) in 20 people with familial partial lipodystrophy, a rare condition causing abnormal fat distribution and metabolic problems. The study aimed to see if the drug could lower high triglycerides and improve blood sugar co…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can a smartphone app replace doctor visits for arthritis patients?
Disease control Stopped earlyThis study tested whether using a smartphone app and a hand grip device could help people with rheumatoid arthritis manage their condition with fewer in-person doctor visits. About 94 adults with active rheumatoid arthritis were randomly assigned to use the app or continue standa…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Heart drug for diabetics shows promise but trial ends early
Disease control Stopped earlyThis study tested whether pemafibrate, a drug that lowers triglycerides, could reduce heart attacks, strokes, and heart-related deaths in over 10,000 people with type 2 diabetes and high triglycerides. Participants took either pemafibrate or a placebo twice daily. The trial was t…
Phase 3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Alzheimer's drug simufilam trial halted Mid-Study
Disease control Stopped earlyThis study tested a drug called simufilam in over 1,000 people with mild-to-moderate Alzheimer's disease. Participants took either 50 mg, 100 mg, or a placebo twice daily for 76 weeks. The goal was to see if simufilam could slow memory loss and help with daily activities. However…
Phase 3 • Sponsor: Cassava Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Triple therapy for melanoma: hope or hype?
Disease control Stopped earlyThis phase 3 study tested whether adding an immunotherapy drug (spartalizumab) to two targeted therapy drugs (dabrafenib and trametinib) works better than the targeted drugs alone for people with advanced BRAF V600 mutant melanoma. The trial enrolled 568 participants but was term…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 26, 2026 18:27 UTC
-
Can a sleep machine keep your heart in rhythm?
Disease control Stopped earlyThis study looked at whether using a positive airway pressure (PAP) machine at night can reduce the return of atrial fibrillation (an irregular heartbeat) in people who also have obstructive sleep apnea. About 129 participants with both conditions were assigned to receive either …
Sponsor: Philips (China) Investment CO., LTD • Aim: Disease control
Last updated Jun 26, 2026 18:05 UTC
-
Experimental drug zavesca tested for rare fatal brain diseases in infants
Disease control Stopped earlyThis phase 3 trial tested the drug miglustat (Zavesca) in 30 infants with Sandhoff or Tay-Sachs diseases, rare genetic disorders that destroy nerve cells. The goal was to see if the drug could reduce hospitalizations, seizures, and feeding problems while improving motor function.…
Phase 3 • Sponsor: Tehran University of Medical Sciences • Aim: Disease control
Last updated Jun 26, 2026 17:51 UTC
-
Experimental kidney drug for alport syndrome falls short in early trial
Disease control Stopped earlyThis phase 2 trial tested a weekly injection of lademirsen in 43 adults with Alport syndrome, a genetic condition that damages kidneys. The goal was to see if the drug could slow the decline in kidney function. The study was terminated early, so the results are limited and it's u…
Phase 2 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jun 26, 2026 16:08 UTC
-
Insulin showdown: toujeo vs tresiba for diabetics with kidney disease
Disease control Stopped earlyThis study compared two long-acting insulins, Toujeo and Tresiba, in people with type 2 diabetes who also have kidney problems and had never used insulin before. The goal was to see which one controls blood sugar better and causes fewer low blood sugar events. The trial was stopp…
Phase 4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 14:43 UTC
-
Hepatitis b cure hope fades as early trial ends
Disease control Stopped earlyThis small phase 2 trial tested whether giving hepatitis B antibodies (HBIG) could clear the hepatitis B surface antigen in people with chronic hepatitis B. Only 13 patients were enrolled before the study was terminated. The goal was to see if a 12-week course of injections could…
Phase 2 • Sponsor: Hannover Medical School • Aim: Disease control
Last updated Jun 26, 2026 13:38 UTC
-
New hope for kids with tough neuroblastoma? trial tests stronger therapies
Disease control Stopped earlyThis phase 2 trial tested two stronger treatment plans for children with very high risk neuroblastoma whose cancer did not respond well to initial chemotherapy. The treatments combined radioactive therapy (mIBG), chemotherapy drugs (topotecan and thiotepa), and a stem cell transp…
Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 26, 2026 13:21 UTC
-
New automated insulin system tested in tiny trial
Disease control Stopped earlyThis study tested a system that automatically adjusts insulin delivery using a continuous glucose monitor, a smartphone app, and an insulin pump. It aimed to see if the system could help adults with type 1 diabetes spend more time with their blood sugar in a healthy range. Only o…
Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 26, 2026 12:39 UTC
-
Hospitals could screen every patient for hepatitis c
Diagnosis Stopped earlyResearchers at a French hospital are testing whether offering hepatitis C screening to all adult inpatients is practical and useful. The study enrolls adults admitted to the hospital who agree to a blood test. The team measures how many patients get screened, how many test positi…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Diagnosis
Last updated Sep 17, 2026 00:00 UTC
-
One prick, three diseases: new rapid test under study
Diagnosis Stopped earlyThis study is testing a new medical device called MagIA IBC that uses a single drop of blood from a finger prick to screen for HIV, hepatitis B, and hepatitis C at the same time. Researchers will enroll 252 adults who are known or suspected to have one of these infections. The go…
Sponsor: MagIA Diagnostics • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
Can less dye and less radiation still spot appendicitis?
Diagnosis Stopped earlyResearchers are testing a CT scan that uses less contrast dye and lower radiation to diagnose appendicitis in young adults. The study compares this low-dose approach against standard dosing to see if it still gives accurate results. Participants are emergency patients with suspec…
Sponsor: Bohyun Kim • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
A Parent's smartphone video could be a new tool to screen kids for sleep apnea
Diagnosis Stopped earlyThis study tests whether a 10-minute video of a sleeping child, recorded by parents on a smartphone, can help identify obstructive sleep apnea. The video analysis will be compared with standard sleep monitoring and a clinical questionnaire in children aged 3 to 10 who snore. If t…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
AI reads eye photos to spot Diabetes-Related vision loss
Diagnosis Stopped earlyThis study tests whether an artificial intelligence program called NeoRetina can accurately detect diabetic retinopathy and diabetic macular edema from simple eye photographs. Researchers will compare the AI's analysis to standard exams by eye doctors. The goal is to see if this …
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
Super-Fine ultrasound could spare melanoma patients a second surgery
Diagnosis Stopped earlyThis trial investigates whether a new, ultra-high-frequency ultrasound device can accurately measure the depth of skin melanomas before surgery. Currently, doctors must remove the tumor, measure its depth under a microscope, and then often perform a second surgery to remove more …
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Tears may replace spinal taps for MS diagnosis
Diagnosis Stopped earlyThis study tests whether a tear sample can diagnose primary progressive multiple sclerosis (MS) as accurately as a spinal tap. Currently, doctors need to collect spinal fluid to confirm this type of MS, which is invasive and uncomfortable. Researchers will compare proteins in tea…
Sponsor: Lille Catholic University • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New Light-Based scanner aims to spot inflammation without needles
Diagnosis Stopped earlyThis study tested a new imaging tool called multispectral optoacoustic tomography (MSOT) to see if it could safely detect inflammation in people with graft-versus-host disease, Crohn's disease, or colitis. The device uses light and sound to create images of inflamed areas. The tr…
Sponsor: University of Oklahoma • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Ultrasound vs. MRI: spotting fetal gut twist risk before birth
Diagnosis Stopped earlyThis study looked at whether a third-trimester ultrasound can accurately find bowel rotation issues in fetuses that raise the risk of a life-threatening twist (volvulus). Researchers compared ultrasound results with fetal MRI, the current best method. The study included 77 pregna…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Neck-Worn swallow detector fails key test
Diagnosis Stopped earlyThis study tested a wearable device that sits on the neck to detect swallowing problems in people with conditions like stroke, Parkinson's, multiple sclerosis, Alzheimer's, or dementia. The device was compared to a standard X-ray test. Unfortunately, the device did not meet the a…
Sponsor: Société des Produits Nestlé (SPN) • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Testosterone cream may stop repeat UTIs in older women
Prevention Stopped earlyThis study tests whether a vaginal testosterone cream can prevent repeat urinary tract infections (UTIs) in postmenopausal women aged 60-90 who have had at least three UTIs. Participants will apply the cream or a placebo for 9 months and be monitored for infections. The goal is t…
Phase 4 • Sponsor: Jefferson Drapkin • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can a vegan diet shield police officers from heart disease?
Prevention Stopped earlyResearchers are testing whether a plant-based diet can improve heart health in police officers who are overweight or have type 2 diabetes. The trial enrolls 20 officers from the Washington, D.C. police department and randomly assigns them to either follow a vegan diet with weekly…
Sponsor: Physicians Committee for Responsible Medicine • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can an online class help teens make safer choices?
Prevention Stopped earlyThis study tests a fully online program called Yes and Know for teens aged 14-19. The program includes group sessions and digital tools to teach about sexual health, relationships, and life skills. About 1,200 teens will take part, with half receiving the program and half receivi…
Sponsor: ETR Associates • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Could a Mother's Omega-3 supplement shield preterm Babies' lungs?
Prevention Stopped earlyThis trial tests whether giving mothers a DHA-rich omega-3 supplement after delivering very preterm (before 29 weeks) could improve their babies' chances of surviving without bronchopulmonary dysplasia, a chronic lung condition. Half the mothers receive DHA capsules, and half rec…
Phase 3 • Sponsor: CHU de Quebec-Universite Laval • Aim: Prevention
Last updated Aug 15, 2026 00:00 UTC
-
Experimental drug aims to prevent bleeding veins in fatty liver disease
Prevention Stopped earlyThis study tested a drug called belapectin to see if it could prevent the formation of esophageal varices (enlarged veins in the esophagus) in people with NASH cirrhosis and signs of high blood pressure in the liver. The trial enrolled 357 adults and compared belapectin to a plac…
Phase 2/3 • Sponsor: Galectin Therapeutics Inc. • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
Infection-Fighting stitches tested for C-Sections, but trial stopped early
Prevention Stopped earlyThis study tested whether using stitches coated with an antibacterial agent (triclosan) could reduce infections after cesarean delivery. Over 1,100 women were planned to take part, but the trial was stopped early. Because it was terminated, we cannot draw firm conclusions about w…
Phase 4 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
New program aims to prevent problems in adopted kids
Prevention Stopped earlyThis study tested a special program called ADAPT for families who adopted children from foster care. The program includes sessions on trust, behavior management, and dealing with loss. Researchers wanted to see if it could improve children's mental health and prevent family disru…
Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated Jun 27, 2026 12:10 UTC
-
Yoghurt study aimed to curb diabetes risk, but ended early
Prevention Stopped earlyThis study tested whether eating yoghurt daily for 24 weeks could improve blood sugar control in adults with prediabetes (high risk for type 2 diabetes). Only 8 people enrolled, and the study was stopped early, so no firm conclusions can be drawn. The goal was to see if a simple …
Sponsor: Danone Global Research & Innovation Center • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
Cholesterol drug tested to stop dangerous pregnancy complication
Prevention Stopped earlyThis study tested whether the cholesterol-lowering drug pravastatin could prevent preeclampsia in women who had a previous early preterm delivery due to the condition. The trial planned to enroll 1,550 women but was terminated early with only 102 participants. Because it stopped …
Phase 3 • Sponsor: The George Washington University Biostatistics Center • Aim: Prevention
Last updated Jun 27, 2026 08:06 UTC
-
Melanoma vaccine trial halted: hope for recurrence prevention unclear
Prevention Stopped earlyThis phase 3 trial tested a vaccine called POL-103A (Seviprotimut-L) in 504 people with high-risk melanoma who had just had surgery. The goal was to see if the vaccine could prevent the cancer from coming back. However, the study was terminated early, so it is not known whether t…
Phase 3 • Sponsor: Polynoma LLC • Aim: Prevention
Last updated Jun 27, 2026 07:55 UTC
-
Mental health sessions may boost vaccine uptake in latinx communities
Prevention Stopped earlyThis study tested whether adding vaccine discussions to routine behavioral health visits could reduce hesitancy and increase COVID-19 and flu shots among Latinx adults with mental illness. Clinicians used motivational interviewing and could offer a warm handoff to a nurse for vac…
Sponsor: Boston College • Aim: Prevention
Last updated Jun 26, 2026 17:00 UTC
-
Can exercise boost brain and body health during opioid treatment?
Symptom relief Stopped earlyResearchers are testing whether a 12-week exercise program can improve thinking skills, physical fitness, and quality of life for adults in opioid substitution therapy. Participants are randomly assigned to start exercise right away or after a 12-week wait. The study measures cha…
Sponsor: Haukeland University Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Three knee shots go Head-to-Head for lasting arthritis relief
Symptom relief Stopped earlyResearchers at Ohio State University are running a double-blind, randomized trial to compare three single-dose injections for knee osteoarthritis: Zilretta, Synvisc-One, and Monovisc. The study enrolls adults aged 25 to 85 with painful knee osteoarthritis that continues despite p…
Phase 4 • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can Brain-Training games rewire the mind to fight alcohol addiction?
Symptom relief Stopped earlyResearchers at the University of Florida are testing whether computerized cognitive training can help people with alcohol use disorder improve their memory, self-control, and thinking skills during inpatient treatment. Participants complete up to 12 sessions of adaptive brain-tra…
Sponsor: University of Florida • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Two strong painkillers go Head-to-Head in the ambulance
Symptom relief Stopped earlyParamedics in the Netherlands often treat severe pain after trauma with either fentanyl or esketamine, but no one knows if one works as well as the other or if a nasal spray works as well as an IV. The FORE-PAIN trial randomly assigns adults with acute traumatic pain to one of fo…
Phase 3 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Could a High-Fat diet boost brain health in early Alzheimer's?
Symptom relief Stopped earlyThis study looks at whether a ketogenic diet (high-fat, low-carb) is practical and safe for people with early-stage Alzheimer's disease over one year. The diet may provide an alternative energy source for the brain and reduce inflammation. Researchers will track diet adherence, b…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a Quit-Smoking program built for transgender adults help them stop?
Symptom relief Stopped earlyTransgender and gender diverse adults smoke at higher rates than the general population, and stigma, discrimination, anxiety, and depression may make quitting harder. Researchers at Massachusetts General Hospital are adapting an existing smoking cessation program called QUIT, whi…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a flexible night splint ease heel pain as well as a rigid one?
Symptom relief Stopped earlyResearchers at Stanford University are comparing two types of night splints for people with plantar fasciitis, a common cause of heel pain. The trial tests whether a dynamic splint, which allows some foot movement, works as well as a static splint that holds the foot in one posit…
Sponsor: Stanford University • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
WaterPik for your head? study tests scalp massager for flakes and hair loss
Symptom relief Stopped earlyThis study tested a WaterPik-like device to massage and clean the scalp in people with dandruff, seborrheic dermatitis, or hair loss. Only 2 people took part before the study was stopped early. The goal was to see if the device could reduce flaking and redness.
Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can a breathing gadget calm anxious teens?
Symptom relief Stopped earlyThis study tests whether a biofeedback breathing system called Freespira can reduce anxiety and panic symptoms in young people aged 9 to 17. Over 8 weeks, one group uses the device while a control group waits. The goal is to see if the device helps lower anxiety scores on a stand…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New antibody shots aim to stop itchy eyes from birch pollen
Symptom relief Stopped earlyThis study tests two experimental drugs (REGN5713 and REGN5715) given alone or together to reduce eye allergy symptoms caused by birch pollen. About 350 adults with birch pollen allergy will receive the drugs or a placebo and then be exposed to pollen in a controlled setting. The…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New program aims to break the Pain-Depression cycle in older women
Symptom relief Stopped earlyThis study tested a program called PRIME for older women with chronic pain and depression who also have physical disabilities. Nine women took part in nurse-led goal-setting visits and group therapy sessions focused on acceptance and commitment. The goal was to see if this combin…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can a home exercise program help Hispanics/Latinos with MS?
Symptom relief Stopped earlyThis study tested whether a 4-month exercise program done at home could help Hispanic/Latino adults with multiple sclerosis (MS) improve their physical function, manage symptoms, and feel better overall. Participants worked with coaches via video calls and compared results to a c…
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
App for cancer depression fails to launch: trial ends after just one participant
Symptom relief Stopped earlyThis study aimed to see if a smartphone app called IONA Mind could help treat depression in people who have had head and neck cancer. Participants would use the app for 6 weeks and fill out surveys. However, the trial was terminated early after enrolling only 1 person, so no mean…
Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Virtual reality may calm colonoscopy jitters without drugs
Symptom relief Stopped earlyThis trial tests whether a combination of virtual reality and psychotherapy can help people undergoing colonoscopy without sedation feel less anxious and experience less pain. Participants will be randomly assigned to receive the VR-enhanced psychotherapy, a sham VR distraction, …
Sponsor: Grigore T. Popa University of Medicine and Pharmacy • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Web program helps insomniacs kick the pill habit
Symptom relief Stopped earlyThis study tested whether a simple internet-based self-help program could help people with long-term insomnia stop using sleeping pills like benzodiazepines or Z-drugs. The program used sleep restriction and stimulus control techniques. 62 adults who had been taking sleep medicat…
Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
New sleep aid trial targets lingering insomnia in depression
Symptom relief Stopped earlyThis study tests if Lemborexant, a sleep medication, can improve sleep in adults whose depression is already treated but who still have insomnia. About 30 participants will take either the drug or a placebo daily for 6 weeks, tracking sleep with diaries and a wearable device. The…
Phase 2 • Sponsor: Unity Health Toronto • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Sugar pills, no lies: could Open-Placebo ease teen depression?
Symptom relief Stopped earlyThis study tests whether placebo pills taken knowingly — called open-label placebo — can reduce depression symptoms in unmedicated teens aged 13–18 with mild to moderate depression. Participants take placebo pills for two weeks while researchers use brain scans to see if the trea…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Can a synthetic cannabinoid calm agitation in frontotemporal dementia?
Symptom relief Stopped earlyThis phase 2 trial tests whether nabilone, a synthetic cannabinoid, can reduce agitation in people with frontotemporal dementia (FTD). Participants receive both nabilone and a placebo in random order to compare effects. The study includes adults with behavioral variant FTD or pri…
Phase 2 • Sponsor: Simon Ducharme, MD • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Could emotional awareness therapy soothe mysterious body aches?
Symptom relief Stopped earlyThis pilot study tests whether a short-term group therapy called Emotional Awareness and Expression Therapy (EAET) can help people with persistent physical symptoms like pain or fatigue that have no clear medical cause. The therapy focuses on helping participants identify and exp…
Sponsor: Daniel Maroti • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Mindful walking may ease knee pain without pills
Symptom relief Stopped earlyThis study tests whether a mindful walking program can help people with knee osteoarthritis walk better and more often. Participants are randomly assigned to either a mindful walking group or a self-care education group, both meeting over 11 sessions in 6 months. The study focuse…
Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Virtual reality could cure stage fright in just one session
Symptom relief Stopped earlyThis study tests whether virtual reality (VR) can help young adults with public speaking anxiety. Participants receive either one or three sessions of VR exposure therapy, followed by a 4-week online program. The goal is to see if a single VR session works as well as multiple ses…
Sponsor: Vilnius University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Numbing ear drops could ease children's ear infection pain faster
Symptom relief Stopped earlyThis trial tests whether adding lidocaine ear drops to standard painkillers provides better ear pain relief for children aged 1–6 with acute otitis media. Half the children receive the ear drops plus usual care (oral painkillers, with or without antibiotics), while the other half…
Phase 3 • Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Depression drug trial halted early – what we know
Symptom relief Stopped earlyThis study tested a new drug called REL-1017 as an extra treatment for adults with major depression who didn't get enough help from standard antidepressants. The trial was stopped early and included only 27 participants. The main goal was to see if the drug could reduce depressio…
Phase 3 • Sponsor: Levomecor Inc. • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Depression drug trial halted: what happened?
Symptom relief Stopped earlyThis study tested a new drug called REL-1017 (esmethadone) as an add-on treatment for people with major depression who weren't helped enough by their current antidepressant. The trial was a Phase 3, double-blind, placebo-controlled study with 236 participants. However, the study …
Phase 3 • Sponsor: Levomecor Inc. • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Hope for rare hunger disorder: new drug enters final testing phase
Symptom relief Stopped earlyThis phase 3 trial tests whether ARD-101 can reduce the intense, constant hunger (hyperphagia) seen in Prader-Willi syndrome. About 90 participants will take either ARD-101 or a placebo daily for 12 weeks. Caregivers will track changes in hunger-related behaviors using a standard…
Phase 3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Ginseng focus trial halted early – little to go on
Symptom relief Stopped earlyThis study tested whether a single 200 mg dose of American Ginseng (Cereboost) could improve attention and brain function in healthy young adults aged 18-40. Participants completed cognitive tests and gave blood samples over 6 hours. However, the trial was terminated early and on…
Sponsor: University of East Anglia • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Balloon treatment for sinusitis may offer faster recovery and less pain
Symptom relief Stopped earlyThis study compared a newer, less invasive procedure called balloon sinuplasty to standard surgery for people with frontal sinusitis that did not improve with medication. The balloon procedure uses a small catheter to open blocked sinus passages, aiming to reduce pain, bleeding, …
Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could a common heart drug tame nosebleeds in rare disease?
Symptom relief Stopped earlyThis study tested whether propranolol, a beta-blocker usually used for heart conditions, can reduce nosebleeds in people with hereditary hemorrhagic telangiectasia (HHT), a genetic disorder that causes abnormal blood vessels. Fifteen adults with HHT took either propranolol or a p…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Parkinson's drug side effect targeted by antioxidant NAC – but trial stalls
Symptom relief Stopped earlyThis study tested whether N-acetylcysteine (NAC), an antioxidant, could help reduce impulse control disorders caused by Parkinson's medications. Only 14 people with mild-to-moderate symptoms were enrolled before the trial was stopped early. The goal was to see if 10 weeks of NAC …
Phase 3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Heart hole closure for migraines? tiny study halted early
Symptom relief Stopped earlyThis study tested whether closing a small hole in the heart (called a PFO) with a device could reduce migraine headaches. It planned to compare the real procedure to a sham (fake) procedure in adults aged 18-55 with frequent migraines. However, the study was stopped early after e…
Sponsor: W.L.Gore & Associates • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Steroid combo fails to show benefit for UC flares
Symptom relief Stopped earlyThis study looked at whether adding high-dose steroid pulses to the usual oral steroid course could help people with moderate ulcerative colitis flares achieve remission without needing other treatments. The trial was terminated early and enrolled 75 adults with left-sided or ext…
Phase 4 • Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Ear device aims to cut opioid use after liver transplant
Symptom relief Stopped earlyThis study tested a small device worn on the ear that uses mild electrical pulses to help control pain after a liver transplant. The goal was to see if it could reduce the need for strong painkillers like opioids. The study was stopped early and included 27 adults waiting for a l…
Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Vitamin c trial for elderly pneumonia fizzles out
Symptom relief Stopped earlyThis study looked at whether giving vitamin C to elderly patients hospitalized with pneumonia could improve their breathing and daily function. Only 9 people took part before the study was stopped early. Because it was so small, we can't say if vitamin C helps or not.
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Gout pain showdown: prednisolone vs colchicine in your Doctor's office
Symptom relief Stopped earlyThis study compared two drugs, prednisolone and colchicine, to see if they work equally well for treating sudden gout attacks in everyday doctor visits. About 186 adults with acute gout pain in their hands or feet took part. The goal was to measure pain relief after three days of…
Phase 4 • Sponsor: University Medicine Greifswald • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Mindfulness app for anxiety in underserved groups fizzles out early
Symptom relief Stopped earlyThis study tested a smartphone app that teaches mindfulness meditation to help Black and Latino adults with anxiety during the COVID-19 pandemic. About 400 participants were assigned to one of two mindfulness programs or a waitlist. The trial was terminated early, so we don't hav…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New approach lets patients start addiction treatment without first going through withdrawal
Symptom relief Stopped earlyThis study tested a new method for starting buprenorphine (a medication for opioid use disorder) in hospitalized adults who also have chronic pain. Instead of requiring patients to stop all other opioids and go through withdrawal first, the new method starts with very low doses o…
Phase 4 • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Tiny study compares trazodone and quetiapine for ICU delirium – but was cut short
Symptom relief Stopped earlyThis pilot study aimed to compare trazodone and quetiapine for treating delirium in ICU patients. It enrolled only 10 adults in the surgical ICU who had delirium with symptoms like agitation or hallucinations. The study was terminated early, so the results are very limited and ca…
Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Can an antioxidant supplement ease bladder troubles in older women?
Symptom relief Stopped earlyThis pilot study tested whether MitoQ, an antioxidant supplement, could improve bladder symptoms like urgency and frequency in women aged 50 and older with metabolic syndrome. Twenty participants took either MitoQ or a placebo for 4 months, tracking their symptoms through questio…
Phase 2 • Sponsor: Iman Al-Naggar, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New moisturizer combo tested for dry skin relief
Symptom relief Stopped earlyThis study tested whether a daily serum and cream could improve skin hydration and reduce redness in people with dry skin. Twenty-one adults applied the products for 14 days. The researchers measured skin moisture and redness before and after treatment to see if the products help…
Sponsor: SCF Pharma • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Mindfulness may ease anxiety for heart device patients
Symptom relief Stopped earlyThis study tested whether a mindfulness program (including meditation, body scans, and gentle yoga) could help people with implanted heart devices like ICDs or pacemakers feel less anxious, stressed, and depressed. The study planned to enroll 34 adults who had recently received s…
Sponsor: Chien Chih-Yin • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Breathing machine showdown: which mode helps obese patients best?
Symptom relief Stopped earlyThis study compared two types of non-invasive breathing support for people with sudden breathing failure who are obese or have sleep apnea. One machine automatically adjusts pressure and volume, while the other uses a fixed pressure setting. The goal was to see which method clear…
Sponsor: University Hospital, Rouen • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Relaxation therapy studied for brain tumor anxiety – but trial cut short
Symptom relief Stopped earlyThis study tested whether adding sophrology (a relaxation method using breathing, visualization, and gentle movement) to speech therapy could reduce anxiety in people with aggressive brain tumors. Only 13 patients were enrolled before the trial was stopped early. The goal was to …
Sponsor: Institut Cancerologie de l'Ouest • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New oxygen device could make throat surgery safer
Symptom relief Stopped earlyThis study tested a device that delivers high-flow oxygen through the nose during throat surgery. The goal was to keep patients' oxygen levels safe without using a breathing tube. The trial included 29 adults in two French hospitals. The device was considered safe if blood oxygen…
Sponsor: CMC Ambroise Paré • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Brain training for psychosis: a small step toward better school performance
Symptom relief Stopped earlyThis study looked at whether adding cognitive remediation therapy (a type of brain training) to supported education (help returning to school) improves academic functioning in young adults with psychotic disorders. Only 9 people enrolled before the study was stopped early. The go…
Sponsor: Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Morphine gel may offer direct relief for chemo mouth sores
Symptom relief Stopped earlyThis study tested a morphine gel applied directly to painful mouth sores caused by chemotherapy. The goal was to see if the gel could relieve pain better than morphine given through an IV. The study included children and young adults aged 5 to 25. The gel was applied four times a…
Phase 3 • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
BPD app trial halted: what happened?
Symptom relief Stopped earlyThis study tested alivis, a smartphone app that teaches coping skills for borderline personality disorder (BPD). It was designed for people aged 18-65 with BPD, who used the app alongside their usual treatment. The goal was to see if the app reduces BPD symptoms, depression, and …
Sponsor: Gaia AG • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Pharmacists step in to treat bladder infections in women
Symptom relief Stopped earlyThis study looked at whether a special protocol used by community pharmacists in France can help women with simple bladder infections (cystitis) get relief more quickly. The goal was to reduce symptoms and avoid unnecessary trips to the doctor or emergency room. The study include…
Sponsor: University Hospital, Angers • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Can retelling and deep breathing ease trauma in terminal cancer?
Symptom relief Stopped earlyThis Phase 2 trial tested a neuroscience-based technique combining memory structuring and deep vagal breathing to reduce PTSD symptoms in people with advanced, incurable cancer and their partners. The study enrolled 19 patients who had just received a terminal diagnosis. The appr…
Phase 2 • Sponsor: Centre Oscar Lambret • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Brain zaps and computer games: a new hope for schizophrenia fog?
Symptom relief Stopped earlyThis pilot study tested whether combining repetitive transcranial magnetic stimulation (rTMS) with computerized cognitive training could help adults with schizophrenia who have thinking and memory problems. Twelve participants received either active or sham rTMS followed by cogni…
Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Hay fever education trial fizzles out: did extra lessons help?
Symptom relief Stopped earlyThis study tested whether teaching teens and young adults (ages 14-29) the correct way to use nasal sprays for hay fever would improve their symptoms compared to standard care. The trial was terminated early and enrolled only 18 participants. The goal was to see if repeat educati…
Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Depression drug trial halted: aticaprant fails to show promise for anhedonia
Symptom relief Stopped earlyThis study tested whether adding aticaprant to standard antidepressants could help people with major depression who still feel no pleasure (anhedonia). The trial was stopped early after enrolling only 101 participants. No results are available, so it is unknown if aticaprant work…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Brainwave training tested for aphasia recovery
Symptom relief Stopped earlyThis study tested whether EEG neurofeedback—a type of brain training that uses real-time brainwave readings—can help people with aphasia (trouble speaking or understanding language) improve their communication, sleep, and anxiety. Seven adults with aphasia from stroke or primary …
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Can the 'Female Viagra' boost Men's sex drive?
Symptom relief Stopped earlyThis small study tested whether flibanserin (Addyi), a drug approved for low sexual desire in women, could also help men with low libido. Eight men aged 18–69 with low desire but normal mood and erectile function took either the drug or a placebo for three months. The trial was t…
Phase 2 • Sponsor: Mohit Khera • Aim: Symptom relief
Last updated Jun 27, 2026 08:15 UTC
-
Can a smartphone app ease Racism-Related stress and curb substance use in young black men?
Symptom relief Stopped earlyThis study tested a mindfulness-based mobile app designed specifically for young Black men (ages 18-29) to help them handle stress from racism and reduce alcohol or marijuana use. Participants used a self-guided app, some with real-time feedback, and reported their daily stress a…
Sponsor: UConn Health • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Can a short daily workout help hospitalized diabetes patients?
Symptom relief Stopped earlyThis study tested whether hospitalized adults with type 2 diabetes or prediabetes could safely do 30 minutes of resistance training each day. The goal was to see if this exercise routine is feasible and if it helps control blood sugar and prevent muscle loss during a hospital sta…
Phase 1 • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New study checks immunotherapy safety in elderly cancer patients
Symptom relief Stopped earlyThis study was designed to track side effects and quality of life in people aged 70 and older with advanced melanoma or non-small cell lung cancer who are starting immunotherapy. Researchers planned to monitor 40 participants for serious side effects and changes in daily well-bei…
Phase 4 • Sponsor: Institut Paoli-Calmettes • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
ADHD drug trial for teens halted early – what we know
Symptom relief Stopped earlyThis study tested a new medicine called NRCT-101SR for teenagers aged 13 to 17 with ADHD. The goal was to see if it safely reduces ADHD symptoms compared to a placebo. The trial was stopped early, so results are limited. It involved 95 participants and used standard ADHD rating s…
Phase 2/3 • Sponsor: Neurocentria, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New study tests safer pain relief for kids with pancreatitis
Symptom relief Stopped earlyThis study tested whether using less opioids for initial pain relief in children with acute pancreatitis is as effective and safer than the usual opioid-first approach. It involved 23 children at Boston Children's Hospital. The goal was to gather data for a larger future trial.
Phase 2 • Sponsor: Boston Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Cough syrup study for infants and toddlers ends early
Symptom relief Stopped earlyThis study looked at how well Petit Drill syrup works and how safe it is for calming throat irritation and dry cough in children from 6 months to 6 years old. The syrup is a soothing substance recommended by the World Health Organization for this age group. The study planned to t…
Sponsor: Pierre Fabre Medicament • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New pill for stubborn hives shows promise, but trial halted early
Symptom relief Stopped earlyThis Phase 2 trial tested an experimental drug called EP262 in 113 people with chronic spontaneous urticaria (long-lasting hives with no clear cause). Participants took either EP262 or a placebo daily for 6 weeks, while continuing their usual antihistamines. The study aimed to se…
Phase 2 • Sponsor: Escient Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Eczema cream aims to end sleepless nights
Symptom relief Stopped earlyThis study tested a prescription cream called ruxolitinib on adults with mild-to-moderate eczema who had trouble sleeping because of their condition. The goal was to see if the cream could help them sleep longer and better. The study was stopped early, but it involved 47 particip…
Phase 4 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Exercise and diet boost mental health in heart infection patients
Symptom relief Stopped earlyThis study tested whether adding physical rehabilitation and personalized nutrition to standard care helps patients with infective endocarditis (a serious heart infection) feel better during their hospital stay. The goal was to improve mental health and quality of life. The study…
Sponsor: Johannes Grand • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Tennis elbow treatment showdown ends early
Symptom relief Stopped earlyThis study compared three different injections—platelet-rich plasma, botulinum toxin, and steroids—for treating tennis elbow pain. It aimed to see which worked best for pain relief. Only 13 people took part before the study was stopped early.
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New hope for painful skin condition? study cut short
Symptom relief Stopped earlyThis study tested a new drug, SAR444656, in 70 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition causing boils and abscesses. Participants took the drug or a placebo for 16 weeks to see if it reduced the number of inflamed nodules and abscesse…
Phase 2 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Can hand exercises and electrical stimulation ease MS sensory problems?
Symptom relief Stopped earlyThis study tested a rehabilitation program for hand sensitivity problems in people with multiple sclerosis. The program used TENS (a mild electrical stimulation device) and hand exercises to improve the ability to feel and recognize objects. The goal was to improve quality of lif…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Can aromatherapy and brain games keep seniors safe at home?
Symptom relief Stopped earlyThis study tested a home system that uses aromatherapy, music, and brain-training games to help older adults with mild memory issues stay safe and independent. Only 4 people took part before the study was stopped early. The goal was to see if seniors would use and enjoy these non…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Could a tiny ear device ease arthritis pain in kids?
Symptom relief Stopped earlyThis study tested whether a small device that sends mild electrical pulses to the vagus nerve (through the ear) can reduce pain and inflammation in children with juvenile idiopathic arthritis. The trial planned to enroll children ages 5 to 18, but was terminated early after only …
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Can a nasal spray calm social anxiety? trial ends early
Symptom relief Stopped earlyThis study tested a nasal spray called PH94B to see if it could quickly reduce anxiety in adults with social anxiety disorder during a public speaking task. About 228 participants were expected to take the spray or a placebo before speaking. The trial was terminated early, so res…
Phase 3 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Virtual hospital tour may calm Moms-to-Be facing early delivery
Symptom relief Stopped earlyThis study tested whether a virtual reality (VR) tour of the delivery room and neonatal unit could reduce anxiety in pregnant women hospitalized with a high risk of preterm birth. The 85 participants were between 24 and 34 weeks pregnant and had received steroids for fetal lung d…
Sponsor: University Hospital, Limoges • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New drug aimed at easing diabetic nerve pain hits roadblock
Symptom relief Stopped earlyThis study tested an experimental drug called GSK3858279 in 147 adults with chronic nerve pain from diabetes. The goal was to see if it could reduce pain better than a placebo. However, the trial was terminated early, so we have less information than planned.
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Shocking: C-Section scar pain study halted early!
Symptom relief Stopped earlyThis study tested if tecar therapy (a type of electrical heat treatment) could reduce pain from cesarean section scars. About 19 women with painful scars received either real tecar therapy or a fake (sham) treatment over 3 weeks, in addition to standard scar massage. The goal was…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New procedure takes on knee pain without surgery
Symptom relief Stopped earlyThis study compares a new minimally invasive procedure called genicular artery embolization (GAE) to standard steroid injections for reducing knee pain from osteoarthritis. It was designed for adults over 40 whose knee pain hasn't improved with other treatments. The goal is to se…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New drug aimed at easing knee pain fails to finish trial
Symptom relief Stopped earlyThis study tested an experimental drug called GSK3858279 in 314 adults with moderate to severe knee osteoarthritis pain. The goal was to find the best dose that reduces pain safely. However, the trial was stopped early, so we have less information than planned.
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Tiny study on blood flow cuffs for shoulder injuries ends early
Symptom relief Stopped earlyThis study tested whether using a blood flow restriction (BFR) cuff during physical therapy could help people with shoulder injuries regain strength and return to activity faster. Only 3 people took part before the study was stopped early. The approach uses a special tourniquet t…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Sleep drug tasimelteon tested for Dream-Acting disorder
Symptom relief Stopped earlyThis pilot study tested whether the sleep drug tasimelteon (Hetlioz) could reduce dream-enactment events in people with REM behavior disorder. Twenty participants took a nightly 20 mg capsule and tracked their symptoms in a daily diary. The study was terminated early, so results …
Early phase 1 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Experimental shot for Cold-Triggered hives tested, but trial stopped early
Symptom relief Stopped earlyThis early-stage trial tested a single dose of a drug called briquilimab in 27 adults with chronic hives caused by cold or friction that did not improve with standard allergy pills. The main goal was to check safety and see if the drug could reduce symptoms. However, the trial wa…
Phase 1/2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Can a video game rewire the brain to ease PTSD?
Symptom relief Stopped earlyThis pilot study tested a digital training task called GAMBIT in 50 adults with PTSD. The goal was to see if playing this brain-training game could improve brain circuit flexibility and reduce PTSD symptoms. The study was terminated early, so the findings are limited.
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
RA patients paired with buddies to boost Well-Being
Symptom relief Stopped earlyThis study tested a program where people with rheumatoid arthritis (RA) were paired with a trained peer supporter for up to 6 months. The goal was to see if sharing experiences and support could improve daily function, medication adherence, and symptoms like pain and fatigue. The…
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Storytime before surgery: could a toy ease Kids' fears?
Symptom relief Stopped earlyThis pilot study looked at whether an interactive storyteller called LUNII could lower anxiety in children aged 4 to 6 with cleft lip and palate before their bone graft surgery. The goal was to see if using the device before the operation would also reduce pain and shorten hospit…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
App aims to tame chemo side effects in breast cancer
Symptom relief Stopped earlyThis study tested a digital health app called medidux™ in 196 people with HER2-positive breast cancer. The app was used for up to 16 weeks during chemotherapy to help track and manage side effects. The goal was to see if using the app reduced the number of severe side effects. Ho…
Sponsor: Palleos Healthcare GmbH • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New running form may ease pain after ACL reconstruction
Symptom relief Stopped earlyThis study tested whether teaching people recovering from ACL reconstruction to run with a forefoot strike and a faster step rate could reduce knee pain and improve function. Ten active-duty soldiers and cadets participated. The approach is non-invasive and focuses on retraining …
Sponsor: Keller Army Community Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Eye tests may predict dry eye relief from artificial tears
Symptom relief Stopped earlyThis study aimed to see if certain eye tests could predict which people with dry eye disease would get relief from over-the-counter artificial tears. Researchers planned to enroll 66 adults with dry eye, but the study was terminated early with only 36 participants. Participants u…
Phase 4 • Sponsor: Tufts Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Robot seal calms dementia patients during care
Symptom relief Stopped earlyThis study tested whether a robotic seal named PARO could help elderly people with moderate to severe memory problems feel calmer during daily care like bathing. The robot was used for a few minutes before and during care, twice a week for 16 weeks. The goal was to see if it redu…
Sponsor: Centre Hospitalier Departemental Vendee • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Can a brain zap and computer game sharpen aging minds?
Symptom relief Stopped earlyThis study tested whether combining a computer-based speed-of-processing training with a gentle electrical brain stimulation (alpha-tACS) could improve how quickly people with mild cognitive impairment process visual information. The trial planned to enroll 40 adults aged 65 and …
Sponsor: Portucalense University • Aim: Symptom relief
Last updated Jun 26, 2026 16:29 UTC
-
Can PET scans reveal hidden heart inflammation after a stroke?
Knowledge-focused Stopped earlyPeople who have a stroke face a much higher risk of heart problems in the following weeks, but researchers do not fully understand why. This study uses PET/MRI scans of the heart and blood tests for inflammatory markers to see whether inflammation develops in the heart after a st…
Sponsor: Luciano A. Sposato • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can zapping the ear during a nap boost memory?
Knowledge-focused Stopped earlyResearchers at the University of California, San Francisco are studying whether stimulating the vagus nerve through the ear during a nap can improve memory. The trial enrolls healthy adults aged 18 to 64 who nap regularly. Participants receive either active stimulation or a sham …
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Brain fatigue after thyroid disease: immune system may be to blame
Knowledge-focused Stopped earlyThis study investigates why some people with Graves' disease continue to feel mentally fatigued even after their thyroid levels return to normal. Researchers will compare blood and spinal fluid from 180 participants—60 with mental fatigue, 60 without, and 60 healthy controls—to f…
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Can imagining future events and brain zaps ease pain and cravings?
Knowledge-focused Stopped earlyThis study looks at whether imagining positive future events (Episodic Future Thinking) and using low-intensity focused ultrasound on the brain can help people with both chronic pain and alcohol use disorder. Ten adults will try these interventions and report changes in pain, cra…
Sponsor: Kirstin M Gatchalian • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Home infusions may help patients stick to treatment
Knowledge-focused Stopped earlyThis study looks at whether people with Fabry, Gaucher, or Hunter disease are more likely to continue their IV treatment when it's given at home versus at a hospital. Researchers will review existing data from 222 patients in Mexico. No new treatments are given; the goal is to un…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Brain imaging may reveal who benefits from depression therapy
Knowledge-focused Stopped earlyThis study looks at brain activity in 100 adults with major depression who are receiving a treatment called accelerated TMS. Researchers use a special brain scanner (TD-fNIRS) to see if patterns of brain activity can predict who will respond well to the treatment. Healthy volunte…
Sponsor: Kernel • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
20-Year review of lymphoma care reveals Real-World treatment success
Knowledge-focused Stopped earlyThis study examines the medical records of 400 people diagnosed with various types of lymphoma at a French hospital between 1999 and 2018. Researchers want to see how long patients survived and whether the care they received matched what medical guidelines recommend. The goal is …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Brain scans reveal sex differences in THC effects for cannabis users
Knowledge-focused Stopped earlyThis study looks at how men and women with cannabis use disorder react differently to THC, the main psychoactive ingredient in cannabis. Researchers will give 40 adults either a THC pill or a placebo and use brain scans to measure changes in reward-related brain activity. The goa…
Phase 2 • Sponsor: Medical University of South Carolina • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can personalized recall timing boost word learning in kids with DLD?
Knowledge-focused Stopped earlyThis study explores whether tailoring when children with developmental language disorder (DLD) practice recalling new words can improve their learning. Researchers compare a standard fixed schedule to an adaptive one that adjusts to each child's progress. Four- and five-year-olds…
Sponsor: Purdue University • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Ultrasound could uncover hidden vascular risks in turner syndrome
Knowledge-focused Stopped earlyThis study is looking at whether yearly ultrasound scans can detect blood vessel abnormalities throughout the body in women with Turner syndrome, not just in the heart area. Turner syndrome is a genetic condition that increases the risk of serious vascular problems, which can sho…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Gene Editing's lasting impact: a 10-Year safety watch
Knowledge-focused Stopped earlyThis study checks on people who previously received gene editing for hemophilia B or mucopolysaccharidosis (MPS) I or II. No new treatment is given; instead, participants are monitored for up to 10 years to see if any new health problems or worsening of existing conditions appear…
Sponsor: Sangamo Therapeutics • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can a coordinated care team ease the aftermath of intensive care?
Knowledge-focused Stopped earlyThis pilot study tests a new approach to supporting people after a stay in the intensive care unit (ICU). Many ICU survivors face ongoing psychological and physical challenges, such as depression, anxiety, and disability. The intervention involves a case manager who coordinates a…
Sponsor: Region Stockholm • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
MRI might reveal hidden pancreatic risks in obesity
Knowledge-focused Stopped earlyThis study investigates whether MRI can detect early signs of pancreatic damage linked to obesity and metabolic syndrome, which are risk factors for pancreatic cancer. Researchers will compare MRI images with tissue samples from patients undergoing pancreatic surgery, as well as …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Scientists block insulin to uncover blood sugar secrets
Knowledge-focused Stopped earlyThis study aims to understand how much insulin the body actually needs to keep blood sugar normal. Ten adults with obesity and high insulin levels will take a drug called diazoxide, which stops the pancreas from making insulin. Researchers will then measure their fasting blood su…
Phase 1 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Biopsies may reveal why some cancers respond to immunotherapy
Knowledge-focused Stopped earlyThis study is looking at whether tumor biopsies can help predict which patients with melanoma, non-small cell lung cancer, or head and neck cancer will respond to immunotherapy drugs called PD-1 or PD-L1 inhibitors. Researchers will collect tissue samples from about 152 adults be…
Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
New study tracks dupilumab for chronic hives in Real-World settings
Knowledge-focused Stopped earlyThis study watches 400 people with chronic spontaneous urticaria (long-lasting hives) who are prescribed dupilumab by their doctor. Researchers collect information from medical records and patient surveys to see how the drug works in real life, its safety, and how it affects qual…
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Hidden toll of diabetes caregiving revealed in new study
Knowledge-focused Stopped earlyThis study looks at how caring for a child recently diagnosed with type 1 diabetes affects caregivers' work, daily life, and well-being. About 100 Canadian caregivers will fill out online questionnaires about their productivity, healthcare use, and quality of life. No treatment i…
Sponsor: PeriPharm • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Eczema study sheds light on skin disease and treatment options
Knowledge-focused Stopped earlyThis study aimed to better understand eczema by collecting data, blood, and skin samples from 69 participants across Canada. It also compared two types of light therapy (broadband vs narrowband UVB) to see which works better for treating eczema. The study was terminated early, so…
Sponsor: Women's College Hospital • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Aged heart cells may hold clues to heart disease progression after attack
Knowledge-focused Stopped earlyThis study looks at whether heart cells that age rapidly after a heart attack release harmful proteins that make heart disease worse. Researchers will collect blood and heart tissue samples from people undergoing coronary artery bypass surgery after a recent heart attack or for s…
Sponsor: South Tees Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Russian study seeks hidden cases of rare liver disease in kids
Knowledge-focused Stopped earlyThis study looks at children and teens in Russia who may have a rare genetic condition called lysosomal acid lipase deficiency (LAL-D). Researchers will check for the disease in up to 1,200 participants using blood tests and genetic testing. The goal is to understand how often LA…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
New MRI scans reveal hidden brain changes after first MS symptoms
Knowledge-focused Stopped earlyThis study used a special MRI technique to look at tiny brain changes in people who recently had a first episode of symptoms that could lead to multiple sclerosis (MS). Researchers compared 84 participants (patients and healthy controls) to see if early memory problems are linked…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Alcohol and cirrhosis: can a quick test spot brain problems?
Knowledge-focused Stopped earlyThis study aimed to see if a short test called BEARNI could detect alcohol-related cognitive impairments (like memory and thinking problems) in people with alcoholic cirrhosis. The researchers planned to enroll patients with cirrhosis, but the study was stopped early after only o…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Skin microbes linked to vitiligo and immunotherapy reactions in melanoma patients
Knowledge-focused Stopped earlyThis study explores whether the community of bacteria living on the skin (the skin microbiome) plays a role in vitiligo—a condition that causes white patches—and in side effects from anti-PD-1 immunotherapy for advanced melanoma. Researchers will collect skin swabs from people wi…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New study explores simple tests to replace colonoscopies for colitis patients
Knowledge-focused Stopped earlyThis study aimed to see if certain substances in stool and blood can predict whether the gut lining has healed in people with moderate to severe ulcerative colitis. Researchers planned to measure these markers in 62 adults before and after treatment. The study was terminated earl…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can brain training help depressed young adults stop ruminating?
Knowledge-focused Stopped earlyThis study tested whether real-time fMRI neurofeedback could help young adults with major depression reduce repetitive negative thinking. Participants received either real or fake feedback while their brain activity was monitored. The trial was terminated early, so the findings a…
Sponsor: Laureate Institute for Brain Research, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Brain test may help match PTSD patients to the right antidepressant
Knowledge-focused Stopped earlyThis study aimed to see if a simple brain-wave test (LDAEP) could predict which veterans with PTSD or depression would improve with the SSRI medication sertraline (Zoloft). Participants took sertraline or a placebo for 14 weeks while researchers measured their brain activity and …
Phase 4 • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Fabry disease sperm study halted early
Knowledge-focused Stopped earlyThis study aimed to find out how common sperm problems are in men with Fabry disease. Researchers planned to check sperm samples from 22 men aged 18 to 65. The study was stopped early, so results are limited.
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a common virus trigger thyroid troubles?
Knowledge-focused Stopped earlyThis study investigated whether polyomaviruses (a type of common virus) are found more often in people with autoimmune thyroiditis or goiters. Researchers compared virus presence in blood, urine, and thyroid tissue from 49 patients undergoing thyroid surgery. The goal was to see …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Brain and eye clues to emotion recognition in autism and psychosis
Knowledge-focused Stopped earlyThis study aimed to understand why people with autism or schizophrenia sometimes struggle to recognize emotions on faces. Researchers used brain wave recordings (EEG) and eye-tracking to see how participants processed facial expressions. The study included people with autism, sch…
Sponsor: Hôpital le Vinatier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Brain zapping study halted early – what it means for mental health
Knowledge-focused Stopped earlyThis study looked at how noninvasive brain stimulation techniques like rTMS, tDCS, and ECT change BDNF levels in people with depression or schizophrenia. Researchers took blood samples before and after stimulation to measure BDNF, a protein linked to brain health. The study was t…
Sponsor: Hôpital le Vinatier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Tiny hairs in fallopian tubes may hold key to ectopic pregnancy
Knowledge-focused Stopped earlyThis study looks at the tiny hair-like structures (cilia) inside the fallopian tubes of women who have had surgery to remove a tube or uterus. Researchers want to see if differences in these cilia help explain why some women have ectopic pregnancies (when a fertilized egg grows o…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Hip replacement study halted early: what it means for pelvic movement
Knowledge-focused Stopped earlyThis study aimed to see how total hip replacement changes the way the pelvic bone moves during daily activities like sitting and standing. Researchers used an ultrasound device to measure pelvic tilt in 15 people with hip arthritis before and after surgery. The study was terminat…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Scientists dive into cells to unravel costello Syndrome's secrets
Knowledge-focused Stopped earlyThis study collects small skin samples from children aged 2 to 17 with Costello syndrome or a related condition. Researchers will analyze the cells to understand how a mutation in the HRAS gene affects energy use and mitochondria. The goal is to learn more about the disease's und…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Tiny study tests exercise during anorexia recovery – results uncertain
Knowledge-focused Stopped earlyThis study looked at whether a gentle, adapted physical activity program could help women with anorexia nervosa during refeeding. Researchers measured changes in a metabolic pathway linked to mood and energy. Only 9 people took part, and the study was stopped early, so the findin…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Smart soles could track walking trouble in nerve disease
Knowledge-focused Stopped earlyThis study tested whether special insoles with pressure sensors (FEETME®) can accurately measure walking speed in people with CIDP, a nerve condition that causes walking difficulties. Researchers compared the insoles to a standard walkway system in 18 adults aged 18-75 with CIDP.…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Sleep study for ICU sedation halted after just 3 volunteers
Knowledge-focused Stopped earlyThis study aimed to see if a sedative called dexmedetomidine produces sleep more like natural sleep than another sedative, propofol. Researchers planned to measure brain activity in 3 healthy volunteers during drug-induced and natural sleep. The trial was terminated early, so onl…
Phase 1 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Tiny nerves may explain chronic cough in diabetes
Knowledge-focused Stopped earlyThis study looked at whether people with type 2 diabetes who have a chronic cough also have damage to small nerves in their skin. Researchers compared diabetic patients with and without chronic cough using nerve tests and skin biopsies. The study was terminated early with only 7 …
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Inhaled cancer drug tested in smokers – early study halted
Knowledge-focused Stopped earlyThis early-stage study tested whether inhaling the cancer drug afatinib works as well as taking it by mouth. Four healthy adult smokers received both forms in separate sessions to compare drug levels in the blood and lungs. The study was terminated early, so the findings are limi…
Phase 1 • Sponsor: Petrov, Andrey • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Brain scans reveal how autistic people process sensory overload
Knowledge-focused Stopped earlyThis study aimed to understand why people with autism often feel overwhelmed by sensory input like bright lights or loud noises. Researchers planned to use virtual reality and brain scans to see how the brain reacts to unpleasant visual stimuli. The study was terminated early and…
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New tool could help patients stay safe on lithium
Knowledge-focused Stopped earlyThis study tested a French version of a questionnaire that measures how much patients know about lithium, a drug used for bipolar and schizoaffective disorders. Researchers wanted to see if higher knowledge scores matched safe lithium levels in the blood. The study included 22 ho…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Tiny brain wave study aims to sharpen Alzheimer's drug testing
Knowledge-focused Stopped earlyThis pilot study measured brain activity (EEG) in 6 healthy volunteers while they performed computer tasks that test attention and memory. The goal was to develop better ways to measure thinking skills that could be used in future Alzheimer's drug trials. The study was terminated…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
PKU diet in childhood may shape adult IQ, study finds
Knowledge-focused Stopped earlyThis study looks at adults with phenylketonuria (PKU) who were diagnosed as newborns and treated with a special diet. Researchers want to see if how long and how strictly they followed the diet as children affects their intelligence (IQ) as adults. The goal is to use this informa…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Sleep troubles linked to suicide attempts? study investigates
Knowledge-focused Stopped earlyThis study looked at whether sleep disorders like insomnia and nightmares are connected to suicide attempts. Researchers compared people who had just attempted suicide with those who had suicidal thoughts but no attempt. The goal was to see if sleep problems might be a trigger. T…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Prenatal alcohol exposure may alter adult brain function, small study suggests
Knowledge-focused Stopped earlyThis study looked at how being exposed to alcohol before birth might affect adults' ability to read emotions and make decisions. Researchers planned to compare adults with prenatal alcohol exposure to those without, using computer tasks. The study was terminated early and only en…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Cleft jaw surgery study cut short: did it help patients?
Knowledge-focused Stopped earlyThis study aimed to see if orthognathic (jaw) surgery improves quality of life for people born with cleft lip and palate. Researchers planned to compare questionnaire scores before and 6 months after surgery in about 10 participants. The study was terminated early, so results are…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Can a video game help manage bipolar disorder?
Knowledge-focused Stopped earlyThis study tested a serious game called Bipolife® for people with bipolar disorder who had already completed a psychoeducation program. The game encourages players to take their medication, keep a daily routine, and contact their doctor if symptoms return. The trial was terminate…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New X-Ray tech could cut radiation and save time for hip surgery patients
Knowledge-focused Stopped earlyThis study looked at whether a newer, low-dose X-ray system (EOSedge) produces images good enough for planning hip replacement or revision surgery, compared to standard digital X-rays. About 97 adults who needed hip surgery X-rays took part. The goal was to see if using just one …
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Blood test may predict dangerous MS rebound after stopping popular drug
Knowledge-focused Stopped earlyThis small, early-terminated study explored whether measuring certain receptors on immune cells could predict disease activity and rebound risk in multiple sclerosis patients taking or stopping ozanimod. Researchers analyzed blood samples from 23 adults with relapsing-remitting M…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Blood markers may forecast diabetes cure after gastric bypass
Knowledge-focused Stopped earlyThis study aimed to find blood and tissue markers that could predict whether obese patients with type 2 diabetes would go into remission after bariatric surgery. Researchers planned to measure 9 specific molecules in blood samples and also collect fat and muscle tissue during sur…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Alzheimer's study probes why patients struggle with daily choices
Knowledge-focused Stopped earlyThis study looked at how early Alzheimer's disease affects a person's ability to make decisions. Researchers tested 100 people with Alzheimer's and healthy volunteers using memory and thinking tasks, plus a special decision-making test. The goal was to understand which brain func…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Alzheimer's drug memantine tested on healthy brains – but study halted early
Knowledge-focused Stopped earlyThis early-stage study aimed to see if taking memantine, an Alzheimer's drug, for 15 days would change certain brain and cognitive markers in healthy young men aged 18-30. The goal was to validate a test battery for future Alzheimer's drug development. However, the study was term…
Phase 1 • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Lung cancer study aims to predict dangerous lung inflammation
Knowledge-focused Stopped earlyThis study followed 83 people with advanced non-small cell lung cancer who were starting standard treatments. The goal was to collect information to help develop a digital tool that can spot early signs of pneumonitis/ILD, a serious lung inflammation that can occur as a side effe…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Scientists hunt for blood clues to tame unpredictable swelling attacks
Knowledge-focused Stopped earlyThis study aimed to find biomarkers (measurable substances in the blood) that could help doctors diagnose bradykinin angioedema and predict how severe attacks might be. The condition causes sudden, unpredictable swelling, and current tests don't work well for all types. Researche…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Mental health study aims to uncover Long-Term heart risks
Knowledge-focused Stopped earlyThis study followed 167 adults with mental health issues like anxiety, depression, or sleep problems who visited their primary care doctor. Researchers used health conversations and a blood test to track lifestyle changes and heart disease risks over up to 20 years. The goal was …
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
VR training for maternity staff aims to improve care, but study ends early
Knowledge-focused Stopped earlyThis study tested a virtual reality training program for maternity care providers, nurses, lactation consultants, and doulas. The goal was to improve teamwork and reduce pain disparities for birthing parents. The study enrolled 66 participants but was terminated early, so the res…
Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Scientists hunt for clues to tell infection apart from inflammation in Kids' joints
Knowledge-focused Stopped earlyThis study looked for new markers in blood and joint fluid to help doctors tell the difference between septic arthritis (a joint infection) and juvenile idiopathic arthritis (an inflammatory condition) in children. Researchers planned to analyze samples from 100 children under 15…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists hunt for genetic and environmental clues in rare lung disease
Knowledge-focused Stopped earlyThis study aimed to describe the features and natural history of idiopathic interstitial pneumopathy, a group of rare lung diseases, in both children and adults. Researchers planned to collect data from 1,600 participants, including medical history, imaging, and genetic tests, to…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New lung camera could replace needle biopsies
Knowledge-focused Stopped earlyThis study aimed to see if a tiny camera on a thin tube (bronchoscopy) could help doctors diagnose diffuse lung diseases without needing a surgical lung biopsy. The camera takes live microscopic images of the air sacs. The study was stopped early, but it involved 38 adults with c…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Gut microbiome study in kids with autoimmune diseases ends early
Knowledge-focused Stopped earlyThis study aimed to compare the gut bacteria of children newly diagnosed with juvenile idiopathic arthritis, type 1 diabetes, or inflammatory bowel disease with those of their healthy siblings. Researchers wanted to see if differences in gut microbes and diet could explain why so…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Massive german study compares new and old heart valve procedures
Knowledge-focused Stopped earlyThis study was a large registry that planned to follow 180,000 patients in Germany with aortic valve problems (leaky or narrowed valves). The goal was to compare newer, less invasive treatments like TAVI with standard open-heart surgery to see which works best and for whom. Resea…
Sponsor: German Aortic Valve Registry • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Could a gentle brain zap quiet voices in schizophrenia?
Knowledge-focused Stopped earlyThis small, early study tested a new approach called Auditory Control Enhancement (ACE) for people with schizophrenia who hear voices (auditory hallucinations) that don't respond to medication. ACE combines a mild brain stimulation technique called tDCS with cognitive training. T…
Sponsor: Brian A Coffman, PhD • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Arthritis drugs and COVID: study probes immune response
Knowledge-focused Stopped earlyThis study looked at how immunosuppressive medications used for rheumatoid arthritis and spondyloarthritis affect the body's ability to fight COVID-19. Researchers measured viral load and immune responses in 150 patients and their infected family members. The goal was to understa…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Opioid choice study halted early after enrolling just 2 people
Knowledge-focused Stopped earlyThis study aimed to understand how withdrawal symptoms and drug-related cues influence decision-making in people with opioid use disorder. Participants completed choice tasks to see if they preferred high-probability rewards. The study was terminated early and only enrolled 2 par…
Early phase 1 • Sponsor: Joshua A. Lile, Ph.D. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Veterans' suicide prevention study tests emotion awareness app
Knowledge-focused Stopped earlyThis study tested a smartphone-based program to help veterans with serious mental illness (like PTSD, bipolar disorder, or schizophrenia) better recognize and describe their emotions. The goal was to see if improving emotion awareness could lower suicide risk. Only 11 veterans to…
Phase 1 • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
MRI scans aim to predict tysabri success in MS patients
Knowledge-focused Stopped earlyThis study looked at whether special MRI scans can detect early brain changes in people with multiple sclerosis who are starting treatment with Tysabri. Researchers planned to follow 70 patients for two years, comparing MRI images before and after treatment. The goal was to find …
Phase 4 • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Small study tests blood sugar targets to prevent lows during exercise in type 1 diabetes
Knowledge-focused Stopped earlyThis study looked at people with type 1 diabetes who use do-it-yourself automated insulin delivery (DIY-AID) systems. Researchers wanted to find the best blood glucose target to set 60 minutes before moderate aerobic exercise (like cycling) to keep blood sugar stable and avoid da…
Sponsor: Institut de Recherches Cliniques de Montreal • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Ibrutinib heart risks under the microscope: can we predict them?
Knowledge-focused Stopped earlyThis study aimed to understand why some people taking the cancer drug ibrutinib develop heart issues like atrial fibrillation (irregular heartbeat) and high blood pressure. Researchers planned to follow 8 patients with blood cancers, using heart tests and blood markers to try to …
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Free diabetes classes for latinos aim to uncover health barriers
Knowledge-focused Stopped earlyThis study looked at Latino adults with diabetes who attended free education classes. Researchers collected information about their health habits, blood sugar levels, and barriers to medical care. The goal was to better understand the needs of this community, not to test a new tr…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Heart study explores Yoga's effect on genes
Knowledge-focused Stopped earlyThis study tested whether a 16-week program of yoga and lifestyle changes could affect gene activity (micro RNA) and heart disease risk factors in 16 adults with coronary artery disease. Participants had either undergone a heart procedure or had non-obstructive heart disease with…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Diabetes Drug's heart benefits probed in tiny, terminated study
Knowledge-focused Stopped earlyThis study aimed to see how dapagliflozin, a diabetes drug, affects blood vessel health in people with type 2 diabetes. Researchers planned to measure blood pressure and other markers of vascular function. However, the trial was terminated early and only enrolled 4 participants, …
Phase 4 • Sponsor: Boston University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Caregiver doubts may fuel schizophrenia relapse
Knowledge-focused Stopped earlyThis study looked at whether caregivers' negative beliefs about antipsychotic medications make it harder for people with schizophrenia to stick to their treatment. About 50 patients and their main caregivers answered questionnaires about medication beliefs and adherence. The goal…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Nose drops with friendly bacteria could pave way for meningitis vaccine
Knowledge-focused Stopped earlyThis study gave healthy adults nose drops containing a harmless bacteria (N. lactamica) to see how the body's immune system responds. The goal is to learn if the immune response is the same whether the bacteria is cleared after 4 days or 14 days. This information will help design…
Sponsor: University Hospital Southampton NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Brain wave test could spot stubborn depression
Knowledge-focused Stopped earlyThis study aimed to find brain and movement markers in people with a type of depression that doesn't respond to standard antidepressants, called anhedonic depression. Researchers measured brain waves (P300), walking speed, and hand movements in 36 participants. The goal was to id…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Can your personality change your diabetes genes?
Knowledge-focused Stopped earlyThis study looked at whether people with type 1 or type 2 diabetes who have a 'Type A' (impatient, proactive) or 'Type B' (calm, slow) personality show different genetic markers linked to inflammation and stress. Researchers planned to collect blood samples and have participants …
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Diabetes drug may alter your taste buds and food desires
Knowledge-focused Stopped earlyThis study looked at how the diabetes medication Liraglutide (Victoza) affects taste, food cravings, and eating habits in people with type 2 diabetes who are overweight. Researchers compared three groups: patients starting Liraglutide, diabetic patients not on the drug, and healt…
Phase 4 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Brain scans reveal Serotonin's role in food avoidance in anorexia
Knowledge-focused Stopped earlyThis study looked at how serotonin, a brain chemical, affects circuits involved in avoiding food in people with anorexia nervosa. Researchers used PET and fMRI scans to compare brain activity between 30 women with anorexia and 27 healthy women. The goal was to understand the brai…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Eczema Drug's skin secrets under the microscope
Knowledge-focused Stopped earlyThis study looked at how the drug tralokinumab affects the skin of people with moderate to severe atopic dermatitis (eczema). Researchers measured drug levels and immune changes in skin samples after 16 weeks of treatment. The goal was to better understand how the drug works, whi…
Phase 2/3 • Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Scientists investigate why ventilators may worsen lung infections
Knowledge-focused Stopped earlyThis study looked at how mechanical ventilation (breathing machines) affects the energy centers (mitochondria) of immune cells in patients with severe lung infections and acute respiratory distress syndrome (ARDS). Researchers aimed to understand why some patients get worse despi…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Early eating study for diabetes ends early
Knowledge-focused Stopped earlyThis study looked at whether eating most calories before 2 PM could help control blood sugar in people with type 2 diabetes. It planned to enroll 10 participants but was terminated after only 2 joined. The goal was to compare early eating with a typical eating pattern over six da…
Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Yale study tests if a pep talk boosts depression drug – but only one person joined
Knowledge-focused Stopped earlyThis study aimed to see if giving patients extra encouragement before and after esketamine treatment could improve their depression symptoms. Researchers planned to compare a group that received a positive presentation and follow-up session with a group that did not. However, the…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Scientists tap into Sleepwalkers' minds to unlock secrets of sleep
Knowledge-focused Stopped earlyThis study aimed to understand what happens in the mind during sleep by using sound cues in people who sleepwalk. Researchers wanted to see if they could trigger and measure mental processes in real time. The study was terminated early, so results are limited.
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
MRI scans aim to uncover hidden ear damage in CMV survivors
Knowledge-focused Stopped earlyThis study looked at whether people born with cytomegalovirus (CMV) infection who have hearing loss or balance problems also have a condition called endolymphatic hydrops (fluid buildup in the inner ear). Researchers used a special MRI scan with a contrast dye to check for this f…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Sleep apnea linked to hidden heart damage, study finds
Knowledge-focused Stopped earlyThis study aimed to find early signs of heart and blood vessel damage in people with obstructive sleep apnea, before serious symptoms appear. Researchers planned to follow 133 patients and check if CPAP treatment could reverse these early changes. The study was terminated early, …
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Sleep apnea study probes fat inflammation – CPAP may help
Knowledge-focused Stopped earlyThis study aimed to see if using a CPAP machine (a device that helps breathing during sleep) reduces inflammation in fat tissue for people with sleep apnea, both obese and non-obese. Researchers planned to compare CPAP treatment to a placebo in 40 men. The study was stopped early…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Timing delivery for gestational diabetes: What's the safest week?
Knowledge-focused Stopped earlyThis study aimed to find the best time (between 37 and 39 weeks of pregnancy) to deliver babies of women with poorly controlled gestational diabetes. Researchers planned to enroll up to 3,450 pregnant women but stopped early with 304 participants. The goal was to see which delive…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Can a Stick-On sensor replace finger pricks before surgery?
Knowledge-focused Stopped earlyThis pilot study tested whether continuous glucose monitors (CGMs) could be used in the days before and after surgery to track blood sugar in people with diabetes. Researchers placed a CGM sensor on 22 patients during a preoperative visit and compared its readings to standard fin…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Sleep apnea study tracks heart risks years later
Knowledge-focused Stopped earlyThis study contacted 321 people with sleep apnea who were part of earlier research to see what health problems they had over time. Researchers asked about heart issues, diabetes, cancer, and deaths. They also looked at whether using a CPAP machine affected these outcomes. The goa…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Wearable device aims to track MS progression from home
Knowledge-focused Stopped earlyThis study tested a wearable device called Syde® in 86 people with multiple sclerosis. Participants wore the device for one month every six months over two years. The goal was to see if the device's activity data matches standard clinic tests like walking speed and disability sco…
Sponsor: SYSNAV • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Baclofen safety study halted early: what we learned
Knowledge-focused Stopped earlyThis study tracked 239 adults in France taking baclofen for alcohol use disorder. Researchers called participants monthly for a year to see how many stopped the drug due to side effects. The goal was to better understand which side effects are caused by baclofen versus other fact…
Phase 4 • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Filmed consultations aim to decode eczema discomfort in babies under 6 months
Knowledge-focused Stopped earlyThis study filmed consultations between dermatologists and infants under 6 months old with atopic dermatitis (eczema). Researchers analyzed the videos to identify specific behaviors that might indicate discomfort, since standard itch assessment scales don't work for babies this y…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Sleep apnea patients stop CPAP for 2 weeks – Here's what scientists learned
Knowledge-focused Stopped earlyThis study involved 65 adults with obstructive sleep apnea who had been using CPAP therapy for at least 6 months. Participants stopped using CPAP for 2 weeks so researchers could measure changes in blood vessel function and nerve control of the heart. The goal was to see if a spe…
Sponsor: Raphael Heinzer • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Gut bacteria clues in anorexia: small study halted early
Knowledge-focused Stopped earlyThis study looked at how food intake relates to gut bacteria in women with anorexia nervosa compared to healthy volunteers. Researchers analyzed stool samples to measure immune-coated bacteria and dietary habits. The study was terminated early with only 14 participants, so findin…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Scientists probe immune cells in pneumonia to unlock ARDS secrets
Knowledge-focused Stopped earlyThis study looked at how certain immune cells, called non-conventional T cells, behave in patients with severe pneumonia and acute respiratory distress syndrome (ARDS). Researchers collected blood and airway samples from 258 intensive care unit patients to track these cells over …
Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Elderly arthritis study reveals hidden health risks
Knowledge-focused Stopped earlyThis study aimed to understand how age influences serious health issues like infections, cancer, heart disease, and bone fractures in people with rheumatoid arthritis. Researchers compared patients over 65 with younger adults (18-50) who had the same disease. The study was stoppe…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Sjögren's dry eye study probes corneal nerve damage
Knowledge-focused Stopped earlyThis study aimed to find out how many people with Sjögren's dry eye have reduced feeling in their cornea (the clear front part of the eye). Researchers measured corneal sensitivity, tear production, and pain in 103 adults with confirmed Sjögren's syndrome and dry eye. The study w…
Sponsor: Dompé Farmaceutici S.p.A • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Home help for dementia caregivers: study ends early with few answers
Knowledge-focused Stopped earlyThis study aimed to see if introducing formal home help (like a paid aide) improves the quality of life for people caring for elderly relatives with memory or thinking problems. Researchers planned to follow 12 caregivers for 90 days, measuring changes in their well-being, stress…
Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Rare disease mystery: scientists watch AMN progress in hopes of finding a cure
Knowledge-focused Stopped earlyThis study followed 65 adult men with a rare inherited nerve disease called AMN (a form of spastic paraplegia) to understand how their symptoms change over time. Researchers collected data on walking ability and quality of life. The goal was to fill gaps in knowledge about the di…
Sponsor: SwanBio Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Wireless heart monitor for infants tested, but study ends early
Knowledge-focused Stopped earlyThis study aimed to see if a wireless sensor could collect health information from babies with heart defects at home, replacing wired devices. Only 2 infants were enrolled before the study was stopped. The goal was to understand if the wireless device was easy to use and worked w…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Scientists track HPV's secret life in young women
Knowledge-focused Stopped earlyThis study followed 190 young women to learn how the body handles new HPV infections. Researchers measured virus levels, immune cells, and other factors over time. The goal was to understand why some infections clear quickly while others persist. No treatment was given; this was …
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Smartphone app tracks suicide risk when starting antidepressants
Knowledge-focused Stopped earlyThis study looked at why some people have more suicidal thoughts when they start or switch antidepressants. 38 adults with major depression used a smartphone app to rate their dark thoughts and mood daily for 30 days. The goal was to better understand and monitor this early risk …
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Lab study explores how JAK inhibitors affect immune cells in arthritis
Knowledge-focused Stopped earlyThis study looked at how JAK-STAT inhibitors, a type of drug used for rheumatoid arthritis, affect certain immune cells called regulatory B cells. Researchers analyzed blood samples from 27 patients to see if these drugs could boost anti-inflammatory functions. The study was term…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Scientists probe immune cells in arthritic joints for clues
Knowledge-focused Stopped earlyThis pilot study analyzed special immune cells called regulatory T cells (Tregs) in the joint fluid of 19 people with rheumatoid arthritis during a flare-up. Researchers compared these cells to Tregs in the blood to understand how they behave in inflamed joints. No treatment was …
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Mindfulness for caregivers: a Stress-Reduction experiment that ended early
Knowledge-focused Stopped earlyThis study aimed to see if a mindfulness-based stress reduction program could lower stress and inflammation in people caring for someone with a severe psychiatric disorder. Researchers planned to compare a group taking mindfulness classes with a group receiving standard care, mea…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Can an eHealth program help teachers support kids with ADHD, autism, and learning disabilities?
Knowledge-focused Stopped earlyThis study tested an online program called Teacher Help, designed to train teachers in evidence-based strategies for students with ADHD, autism spectrum disorder, or learning disabilities. Teachers worked through six online sessions with support from school psychologists. The goa…
Sponsor: IWK Health Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Hidden heart condition: study seeks to uncover missed diagnosis in heart failure patients
Knowledge-focused Stopped earlyThis study aims to find out how common transthyretin amyloidosis cardiomyopathy (ATTR-CM) is in Russian patients with a certain type of heart failure. Researchers will review medical records and then invite some patients for extra heart tests to confirm or rule out ATTR-CM. The g…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:47 UTC
-
Study on arthritis and diabetes link halted early
Knowledge-focused Stopped earlyThis study looked at whether people with both rheumatoid arthritis and type 2 diabetes have a harder time controlling their diabetes than those with osteoarthritis and diabetes. Researchers planned to follow 176 adults to see how quickly they needed new diabetes treatments. Howev…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:07 UTC
-
COVID-19 vaccine response under scrutiny in autoimmune patients
Knowledge-focused Stopped earlyThis study looked at how well the COVID-19 vaccine triggers an immune response in people with autoimmune or inflammatory diseases who take immunosuppressants or biologics. Researchers took blood samples before vaccination and at several points after to measure antibodies and T-ce…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:24 UTC
-
Real-World antibiotic study cut short: what we can learn
Knowledge-focused Stopped earlyThis study tracked how the antibiotic ceftazidime-avibactam is used in real hospital settings in China for serious infections like pneumonia and abdominal infections. Researchers planned to enroll 450 patients but the study was terminated early. The goal was to see how often the …
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:39 UTC
-
Can a simple ultrasound replace MRI for Crohn's? small study investigates
Knowledge-focused Stopped earlyThis study looked at using point-of-care ultrasound (POCUS) to assess small bowel Crohn's disease. Researchers interviewed doctors, nurses, and patients to understand if POCUS could be useful in the NHS. They also compared how POCUS and MRI scans affected doctors' treatment decis…
Sponsor: Nottingham University Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:32 UTC